{"text": "Follow - up period : Mean 10.1 years .Outcomes : Total invasive cancer , excluding nonmelanoma skin cancer .Secondary outcomes were breast , colorectal , and lung cancer .", "label": "", "metadata": {}, "score": "23.544453"}
{"text": "At the population level , the model predicted decreases in incidence and mortality from ovarian , colorectal , and endometrial cancers , and increases in breast cancer incidence and mortality .", "label": "", "metadata": {}, "score": "25.429005"}
{"text": "While advances in surgery , chemotherapy , and radiation therapy over the past 20 years have led to improved outcomes , overall 5-year survival is only 42 percent for ovarian cancer compared with 88 percent for breast cancer and 63 percent for colorectal cancer .", "label": "", "metadata": {}, "score": "31.428394"}
{"text": "Using the annual rates of death from breast or colorectal cancer in the intervention and control groups for each study , we reported the pooled absolute risk reductions by year , as well as the number of years needed to achieve specific thresholds of absolute risk reduction .", "label": "", "metadata": {}, "score": "36.543476"}
{"text": "Overall rates were lowest among Hispanics , and very little difference was found by SES group .Colorectal cancer mortality rates were highest in the Intermediate SES counties for each group ( Table 3 ) .", "label": "", "metadata": {}, "score": "36.82756"}
{"text": "Mortality benefits varied from study to study ( web appendix 1 ) .The benefit in colorectal cancer mortality increased steadily with longer follow - up , reaching 23 colorectal cancer deaths prevented for 10 000 people screened ( 3.0 to 42 ) at 15 years .", "label": "", "metadata": {}, "score": "37.91127"}
{"text": "There were no significant associations observed in other site - specific analyses ( data not shown ) .Cancer case fatality and all - cause mortality after a cancer diagnosis .", "label": "", "metadata": {}, "score": "38.853428"}
{"text": "The evidence is insufficient to determine the effects of hormone therapy on the incidence of ovarian cancer , mortality from breast cancer or CHD , or all - cause mortality .", "label": "", "metadata": {}, "score": "39.46119"}
{"text": "Among all patients in the trials , the 15-year cumulative incidence of death from breast cancer was 4.7 % or less for all treatment groups .", "label": "", "metadata": {}, "score": "39.46427"}
{"text": "The cancers examined in this analysis included lung , colorectal , female breast , prostate , cervical , and all cancers collected by TCR combined .", "label": "", "metadata": {}, "score": "40.937103"}
{"text": "However , the quality - of - life impact of those harms , particularly stroke and MI , may be substantial .The benefit - to - harm ratio for both incident benefits and harms , and mortality from those outcomes , from using OCs as a primary preventive agent is substantially improved when potential reductions in colorectal and endometrial cancers are included .", "label": "", "metadata": {}, "score": "41.228386"}
{"text": "Cancer mortality .A total of 51 diabetic and 856 nondiabetic participants died of cancer during follow - up , corresponding to age - adjusted cancer mortality rates of 4.17 and 3.12 per 1,000 person - years , respectively .", "label": "", "metadata": {}, "score": "41.462254"}
{"text": "Among white non - Hispanics , the Low SES counties actually had lower mortality rates than did the High SES counties for all cancer sites combined , lung , colorectal , and female breast cancer .", "label": "", "metadata": {}, "score": "41.70033"}
{"text": "This analysis was limited to invasive cancers only .The cancers examined in this analysis included lung , colorectal , female breast , prostate , cervical , and all cancers collected by TCR combined .", "label": "", "metadata": {}, "score": "42.783463"}
{"text": "Outcomes such as mortality , disease progression , lymph node metastasis and distant metastasis were examined .The authors approached this systematic review in a standardized , objective manner by applying a number of statistical analyses to this study .", "label": "", "metadata": {}, "score": "43.219795"}
{"text": "What this study adds .Screening for colorectal cancer ( fecal occult blood testing ) or breast cancer ( mammography ) takes roughly 10 years on average to prevent one death for every 1000 patients screened .", "label": "", "metadata": {}, "score": "43.247204"}
{"text": "However , even with implementation of novel therapeutic options and preventative measures , most cancers are currently diagnosed at late stages , when treatment therapies are least effective .", "label": "", "metadata": {}, "score": "43.529297"}
{"text": "The available evidence suggests that incident harms associated with OC use are likely to exceed prevented cases of ovarian cancer .The overall net effect of current patterns of OC use on deaths from noncontraceptive outcomes is positive , with reductions in mortality from ovarian , colorectal , and endometrial cancers exceeding increased deaths from breast cancer and vascular events .", "label": "", "metadata": {}, "score": "44.23507"}
{"text": "Differences in patient selection and disease etiology could also explain the heterogeneity between studies of colorectal carcinomas .In addition , rectal carcinomas have different biological , clinicopathologic and therapeutic implications from colon carcinomas [ 52 , 81 ] .", "label": "", "metadata": {}, "score": "44.29368"}
{"text": "Cancer incidence .During 17 years of follow - up , 116 diabetic and 2,365 nondiabetic adults developed cancer , corresponding to age - adjusted incidence rates of 13.25 and 10.58 per 1,000 person - years , respectively .", "label": "", "metadata": {}, "score": "44.580463"}
{"text": "A \" global index \" included the earliest occurrence of CHD , invasive breast cancer , stroke , PE , endometrial cancer ( only in the CE plus MPA substudy ) , colorectal cancer , hip fracture , or death due to other cause .", "label": "", "metadata": {}, "score": "44.88546"}
{"text": "This has led to intense research efforts to identify effective screening strategies for ovarian cancer , but results have been disappointing , particularly with regard to decreases in mortality .", "label": "", "metadata": {}, "score": "45.00769"}
{"text": "Two large U.K. cohort studies showed a significant reduction in endometrial cancer mortality in women with a history of OC use .As with ovarian cancer , the overall strength of evidence is reduced because of the risk of bias in the observational studies .", "label": "", "metadata": {}, "score": "45.11137"}
{"text": "Among participants with colorectal cancer , individuals with diabetes had a higher risk of death from colorectal cancer than those without diabetes .Diabetes also conferred a higher risk of death from all causes in adults who developed a wide array of cancers , including cancers of the colorectum , breast , and prostate .", "label": "", "metadata": {}, "score": "45.411865"}
{"text": "Third , diabetes was associated with greater cancer - specific case fatality for adults with cancer , particularly with colorectal cancer .Fourth , in patients with cancer , individuals with diabetes had higher all - cause mortality than those without diabetes .", "label": "", "metadata": {}, "score": "45.611984"}
{"text": "Adverse effects ( see KQ 5 ) .KQ 4 : .Diagnosis of endometrial cancer , endometrial cancer mortality , diagnosis of colorectal cancer , colorectal cancer mortality .", "label": "", "metadata": {}, "score": "46.266235"}
{"text": "Benefits include reduced risk for fracture ( good evidence ) and colorectal cancer ( fair evidence ) .Combined estrogen and progestin has no beneficial effect on coronary heart disease ( CHD ) and may even pose an increased risk ( good evidence ) .", "label": "", "metadata": {}, "score": "46.5131"}
{"text": "e Includes metastatic and non - metastatic breast cancer , with the exception of in situ breast cancer .f All deaths , except from breast or colorectal cancer , definite or probable CHD , PE , or cerebrovascular disease .", "label": "", "metadata": {}, "score": "46.707634"}
{"text": "For breast cancer mortality , rates were still highest in the Intermediate SES counties , but less difference was found in rates for each race and ethnicity than for incidence rates ( Table 3 ) .", "label": "", "metadata": {}, "score": "47.01744"}
{"text": "However , a recent meta - analysis of other immunohistochemical prognostic markers demonstrated that the cut - off value of the percentage of positively - stained cells used in the scoring criteria appears unlikely to bias the underlying relationship between a prognostic biomarker and mortality [ 74 ] .", "label": "", "metadata": {}, "score": "47.17116"}
{"text": "For colorectal cancer screening , 4.8 years ( 2.0 to 9.7 ) passed before one death from colorectal cancer was prevented for 5000 patients screened .", "label": "", "metadata": {}, "score": "47.503098"}
{"text": "After pooling these trials , we calculated the average mortality benefit .Web appendix 2 shows mortality curves for the individual studies .Discussion .In this survival meta - analysis , we used novel methods to determine quantitative pooled estimates of the time lags to benefit for breast and colorectal cancer screening , based on data from high quality , randomized clinical trials .", "label": "", "metadata": {}, "score": "47.71228"}
{"text": "For these women , the available evidence suggests that the increase in risk of developing breast cancer or having a vascular event is likely to be approximately the same as , or slightly greater than , the decrease in risk of developing ovarian cancer .", "label": "", "metadata": {}, "score": "48.08446"}
{"text": "Incorporating time lag estimates into screening guidelines would encourage a more explicit consideration of the risks and benefits of screening for breast and colorectal cancer .", "label": "", "metadata": {}, "score": "48.129875"}
{"text": "Previous studies did not adopt this more global perspective , instead focusing more specifically on individual relationships with particular cancers , separating the impact on incidence from the impact on mortality .", "label": "", "metadata": {}, "score": "48.25699"}
{"text": "For incident harms and benefits , the likelihood that benefits outweighed harms was less than 40 percent when only prevention of incident ovarian cancer was considered .", "label": "", "metadata": {}, "score": "48.842564"}
{"text": "Date : .Women with ductal carcinoma in situ -- DCIS -- who later develop invasive breast cancer in the same breast are at higher risk of dying from breast cancer than those who do not develop invasive disease , according to a new study .", "label": "", "metadata": {}, "score": "49.13376"}
{"text": "In individuals who developed cancer , adults with diabetes had a higher risk of cancer case fatality ( 1.34 [ 1.002 - 1.79 ] ) and all - cause mortality ( 1.61 [ 1.29 - 2.01 ] ) .", "label": "", "metadata": {}, "score": "49.405155"}
{"text": "Tumor metastasis remains a major cause of cancer mortality [ 3 ] .A major unmet need in the field of oncology is the ability of biomarkers to allow for early characterization of carcinomas according to their aggressive potential .", "label": "", "metadata": {}, "score": "49.430668"}
{"text": "Two studies [ 51 , 52 ] examined the association of fascin-1 positivity of carcinomas with mortality , and three [ 6 , 24 , 54 ] examined the association of high fascin-1 with mortality , with a total of 1,141 colorectal carcinoma cases .", "label": "", "metadata": {}, "score": "49.615875"}
{"text": "No statistically significant associations were observed between diabetes and risks of advanced stage of colorectal or prostate cancer .There were no advanced breast cancer cases in participants with diabetes .", "label": "", "metadata": {}, "score": "49.724556"}
{"text": "Because of insufficient evidence , the USPSTF could not assess the effects of unopposed estrogen on the incidence of breast cancer , ovarian cancer , or colorectal cancer , as well as breast cancer mortality or all - cause mortality .", "label": "", "metadata": {}, "score": "49.759136"}
{"text": "However , it should be noted that each study included different histological types of breast carcinomas .Yoder et al .[19 ] studied primary node - positive and node - negative invasive breast carcinomas , which included infiltrating ductal carcinomas , infiltrating lobular carcinomas , mucinous carcinomas and medullary carcinomas .", "label": "", "metadata": {}, "score": "50.008255"}
{"text": "The effects of OC use on colorectal and breast cancer incidence were a major contributor to the overall balance of harms and benefits , and efforts to resolve remaining uncertainties regarding these two cancers should be prioritized .", "label": "", "metadata": {}, "score": "50.38677"}
{"text": "Overall , the evidence suggesting a trend toward reduction of colorectal cancer risk with combined hormone therapy should be interpreted cautiously until controlled trials clarify whether therapy has either no benefit or modest benefit .", "label": "", "metadata": {}, "score": "50.439034"}
{"text": "Mortality was increased to a lesser degree than incidence .For stroke , projected mortality incidence was decreased , likely due to a younger age distribution in OC users and subsequent higher post - event survival .", "label": "", "metadata": {}, "score": "50.535294"}
{"text": "Two studies [ 50 , 53 ] examined the association of fascin-1 positivity of carcinomas with mortality , with a total of 293 lung carcinoma cases .", "label": "", "metadata": {}, "score": "50.727097"}
{"text": "Breast Cancer .Table E shows the strength of evidence for the effect of OC use on breast cancer .Despite the increased incidence , there was no evidence of increased mortality from breast cancer ( OR , 0.94 ; 95 % CI , 0.87 to 1.02 ) .", "label": "", "metadata": {}, "score": "50.792126"}
{"text": "Studies without results from multivariable analysis [ 19 - 21 , 50 , 53 , 57 , 59 , 60 ] .Note : Time - to - disease progression is defined by the occurrence of the outcomes time - to - mortality , recurrence or metastasis .", "label": "", "metadata": {}, "score": "50.863575"}
{"text": "However , in general , the highest incidence and mortality rates were found in counties categorized as Intermediate SES , but patterns differed by cancer site and by race and ethnicity .", "label": "", "metadata": {}, "score": "50.894226"}
{"text": "Sensitivity analysis was carried out for studies which provided a clear definition that mortality referred to death from cancer .For the studies of colorectal carcinomas , sensitivity analysis was carried out for studies which had included an analysis of patients with stage III / IV colorectal carcinomas in their results .", "label": "", "metadata": {}, "score": "50.940655"}
{"text": "Fifth , we had a limited number of cases to investigate less common cancer sites , such as endometrial , lymphoma , esophageal , and liver cancers .", "label": "", "metadata": {}, "score": "51.0292"}
{"text": "Three studies [ 19 - 21 ] examined the association of fascin-1 with mortality , with a total of 489 breast carcinoma cases .The association of fascin-1 with mortality in breast , colorectal , gastric , lung and esophageal carcinomas .", "label": "", "metadata": {}, "score": "51.04071"}
{"text": "A second sensitivity analysis included only studies of patients with stage III / IV colorectal carcinomas [ 6 , 24 , 51 , 52 ] .", "label": "", "metadata": {}, "score": "51.04419"}
{"text": "The required high frequency of screening , combined with the relatively low incidence of ovarian cancer , would lead to high numbers of false positive results , even with a highly specific test .", "label": "", "metadata": {}, "score": "51.156265"}
{"text": "4 For mammography screening , systematic reviews also suggest that about one in 10 women screened will have a false positive result .37 They also suggest that one in 100 women screened will need a biopsy , and one in 1000 will be subject to overdiagnosis ( that is , diagnosed with a breast cancer that was unlikely to have been clinically evident during their lifetime ) and possibly unnecessary treatment .", "label": "", "metadata": {}, "score": "51.267002"}
{"text": "For breast cancer screening by mammography , it takes only 3.0 years to prevent one death per 5000 women screened , suggesting that for most women with a life expectancy less than three years , the harms likely outweigh the benefits .", "label": "", "metadata": {}, "score": "51.45006"}
{"text": "For breast cancer screening ( by mammography ) , 3.0 years elapsed before one death from breast cancer was prevented for 5000 women screened , and 10.7 years elapsed before one death was prevented for 1000 women screened .", "label": "", "metadata": {}, "score": "51.51384"}
{"text": "We found that 10.3 years were required for the absolute risk reduction to move from 0 to 0.001 ( that is , from no colorectal cancer deaths prevented to one death prevented in 1000 people screened ) .", "label": "", "metadata": {}, "score": "51.598724"}
{"text": "However , the spectrum of absolute risk reductions and time lags to benefit in this study , used with individualized predictions of mortality risk , can promote tailored decision making across a wide range of patient preferences and life expectancies .", "label": "", "metadata": {}, "score": "51.748154"}
{"text": "show an increased risk ( relative risk : 1.98 ; confidence interval : 1.15 , 3.41 ) .With respect to colorectal cancer , it appears that fascin-1 is associated with an increased risk for all four outcomes examined .", "label": "", "metadata": {}, "score": "51.8722"}
{"text": "Primary outcome measures Time to death from breast or colorectal cancer in screened and control populations .Interventions Fecal occult blood testing for colorectal cancer screening , mammography for breast cancer screening .", "label": "", "metadata": {}, "score": "52.17715"}
{"text": "d Not included in \" global index \" .e Results are based on an average follow - up of 6.8 years .f All deaths , except from breast or colorectal cancer , definite or probable CHD , PE , or cerebrovascular disease .", "label": "", "metadata": {}, "score": "52.211765"}
{"text": "Clinical practice guidelines recommend targeting breast and colorectal cancer screening to healthy older patients who have a substantial life expectancy .1 2 A major rationale for this recommendation is that cancer screening is unlikely to benefit patients with a short life expectancy because the benefit from screening is not immediate .", "label": "", "metadata": {}, "score": "52.286766"}
{"text": "Cancer incidence and mortality rates tend to be higher in lower SES populations than in higher SES populations .However , in general , we found the highest incidence and mortality rates in counties that were categorized as Intermediate SES .", "label": "", "metadata": {}, "score": "52.35782"}
{"text": "Although the study examined the association of fascin-1 with mortality , time - to - disease progression , lymph node metastasis and distant metastasis in five major cancer types , the clinical implications of these findings are still unclear and many unanswered questions remain .", "label": "", "metadata": {}, "score": "52.48808"}
{"text": "Colorectal cancer screening .For colorectal cancer screening , we examined the meta - analyses conducted by the Cochrane Collaboration in 2008 11 and the US Preventive Services Task Force report in 2008 1 and identified four trials .", "label": "", "metadata": {}, "score": "52.67971"}
{"text": "Examining all - site cancer rates by each race and ethnicity separately , cancer incidence rates are higher in the Low and Intermediate SES counties compared with the High SES counties ( Table 2 ) [ PDF ] .", "label": "", "metadata": {}, "score": "52.71887"}
{"text": "Clinical implications of fascin-1 .The results of the study by Tan et al .revealed that fascin-1 was associated with an increased risk of mortality for breast , colorectal and esophageal cancers .", "label": "", "metadata": {}, "score": "52.83697"}
{"text": "One strength of this research is that we presented a spectrum of time lags to benefit corresponding to a range of thresholds of absolute risk reduction to help a wide range of patients make informed decisions on breast and colorectal cancer screening .", "label": "", "metadata": {}, "score": "53.586884"}
{"text": "This disease course is very different from that of breast or colon carcinomas that develop through distinct stages to an aggressive phenotype over many years .", "label": "", "metadata": {}, "score": "53.9357"}
{"text": "Ten studies [ 6 , 7 , 9 , 24 , 51 , 52 , 54 - 56 , 58 ] presented multivariable results for the mortality outcome , with a total of 2,501 carcinoma cases .", "label": "", "metadata": {}, "score": "53.94979"}
{"text": "Unfortunately , the size and duration of a randomized trial to definitively address the potential role of OCs as primary prevention for ovarian cancer would be unprecedented .", "label": "", "metadata": {}, "score": "53.967133"}
{"text": "Main results .Aspirin and placebo groups did not differ for incidence of total invasive cancer ( Table ) .Conclusion .Commentary .2 studies by Cook and Lee and their colleagues complete the reporting of primary outcomes from the Women 's Health Study , a trial of low - dose aspirin and high - dose \u03b1 - tocopherol in the primary prevention of CVD and cancer in generally healthy female health care professionals .", "label": "", "metadata": {}, "score": "53.970757"}
{"text": "The two large United Kingdom ( U.K. ) cohort studies had conflicting results for colorectal cancer mortality in women with a history of OC use .", "label": "", "metadata": {}, "score": "54.049675"}
{"text": "Because cancer continues to pose a major threat to human health , it is essential to develop novel methods for combating it .Current approaches include prevention , early detection , discovery of new treatment modalities and combinations of the three , with a significant portion of research dedicated to development of new treatments .", "label": "", "metadata": {}, "score": "54.257763"}
{"text": "For breast cancer screening , 3.0 years ( 95 % confidence interval 1.1 to 6.3 ) passed before one death from breast cancer was prevented for every 5000 women screened .", "label": "", "metadata": {}, "score": "54.547874"}
{"text": "Compared with their nondiabetic counterparts , adults with diabetes were slightly more likely to develop cancer overall ( multivariable - adjusted HR 1.22 [ 95 % CI 0.98 - 1.53 ] ) , especially cancers of the pancreas and digestive system and cancers related to smoking ( Table 2 ) .", "label": "", "metadata": {}, "score": "54.76527"}
{"text": "The probability that a menopausal woman will develop various chronic diseases during her lifetime has been estimated to be 46 percent for CHD , 20 percent for stroke , 15 percent for hip fracture , 10 percent for breast cancer , and 2.6 percent for endometrial cancer .", "label": "", "metadata": {}, "score": "54.777184"}
{"text": "No association with distant metastasis in esophageal carcinomas was observed .Conclusions .Fascin-1 is associated consistently with increased risk of mortality in breast , colorectal and esophageal carcinomas and with metastasis in colorectal and gastric carcinomas .", "label": "", "metadata": {}, "score": "54.850792"}
{"text": "We used this range to show the spectrum of time lags to benefit for breast and colorectal cancer screening .Methods .Design overview .1 2 9 10 11 All trials examined multiple rounds of screening , leading us to focus on the time lag to benefit for multiple rounds of screening , rather than for a single screening test .", "label": "", "metadata": {}, "score": "54.886753"}
{"text": "Singh GK , Miller BA , Hankey BF .Changing area socioeconomic patterns in U.S. cancer mortality , 1950 - 1998 : Part II - Lung and colorectal cancers .", "label": "", "metadata": {}, "score": "55.015163"}
{"text": "Because of insufficient evidence , the USPSTF could not assess the effects of combined estrogen and progestin on the incidence of ovarian cancer , mortality from breast cancer or coronary heart disease , or all - cause mortality .", "label": "", "metadata": {}, "score": "55.164253"}
{"text": "KQ 5 : Diagnosis of breast cancer , cervical cancer , venous thromboembolic event , stroke , or myocardial infarction ; disease - specific mortality associated with these outcomes .", "label": "", "metadata": {}, "score": "55.223347"}
{"text": "Of these , 39 were case - control studies , 10 were cohort studies , and 6 were pooled analyses .None of the pooled analyses met criteria for inclusion in the meta - analyses examining OC use and ovarian cancer incidence .", "label": "", "metadata": {}, "score": "55.46089"}
{"text": "Two large , fair - quality cohort studies conducted in the U.K. found an increased risk of cervical cancer mortality among OC users , with a trend toward increased mortality with a longer duration of use .", "label": "", "metadata": {}, "score": "55.527657"}
{"text": "However , studies of breast and colorectal cancer screening have shown no or conflicting evidence of differences in screening benefit across ages .4 22 In addition , many of our results have wide confidence intervals , precluding definitive comparisons across different populations .", "label": "", "metadata": {}, "score": "55.803314"}
{"text": "The noncontraceptive harms ( increased risk of breast and cervical cancer and vascular events ) and benefits ( decreased risk of ovarian , colorectal , and endometrial cancers ) associated with OC use can affect both quality of life and mortality .", "label": "", "metadata": {}, "score": "56.19065"}
{"text": "The multivariable - adjusted HR of all - cancer mortality was 1.36 ( 95 % CI 1.02 - 1.81 ) comparing adults with and without diabetes ( Table 2 ) .", "label": "", "metadata": {}, "score": "56.353348"}
{"text": "The authors conclude that , regardless of treatment , women with DCIS have an excellent overall prognosis \" despite persistent risks of breast cancer in the same or contralateral breast .", "label": "", "metadata": {}, "score": "56.501396"}
{"text": "Whitlock EP , Lin J , Liles E , Beil T , Fu R , O'Connor E , et al .Screening for colorectal cancer : an updated systematic review .", "label": "", "metadata": {}, "score": "56.5503"}
{"text": "We obtained all publications for each eligible trial in our meta - analysis : four trials for colorectal cancer screening and five trials for breast cancer screening .", "label": "", "metadata": {}, "score": "56.587997"}
{"text": "[21 ] studied invasive ductal carcinoma only , and Rodriguez - Pinilla et al .[20 ] investigated node - negative sporadic and hereditary invasive breast carcinomas .", "label": "", "metadata": {}, "score": "56.757668"}
{"text": "We found preexisting diabetes to be an independent risk factor for death from cancer in adults with any cancer and for colorectal cancer death among adults with colorectal cancer .", "label": "", "metadata": {}, "score": "56.938637"}
{"text": "Our meta - analyses demonstrate that there is strong evidence that fascin-1 protein is associated with an up to two and a half - fold increased risk of mortality in breast , colorectal and esophageal carcinomas .", "label": "", "metadata": {}, "score": "57.099407"}
{"text": "Postmenopausal hormone therapy and the risk of colorectal cancer : a review and meta - analysis .Am J Med .Beral V. Breast cancer and hormone - replacement therapy in the Million Women Study .", "label": "", "metadata": {}, "score": "57.305557"}
{"text": "7 - 11 Persons without insurance are less likely to be screened for cancer , have a usual source of care , have had a health care visit in the past 12 months , and are more likely to delay or not get care due to cost .", "label": "", "metadata": {}, "score": "57.517464"}
{"text": "For these reasons , some experts favor all - cause mortality as an end point in cancer outcomes research that is not biased by attribution of cause of death and captures the full effect of possible interactions ( 23 ) .", "label": "", "metadata": {}, "score": "57.539085"}
{"text": "To combine data from individual studies into a summary best estimate of a pooled time lag to benefit , our goal was to obtain the annual number of cancer deaths and the annual number of participants at risk for each study .", "label": "", "metadata": {}, "score": "57.684605"}
{"text": "Four studies [ 7 , 9 , 58 , 59 ] examined the association of high fascin-1 with mortality and one [ 60 ] examined the association of fascin-1 positivity of carcinomas with mortality , with a total of 972 esophageal carcinoma cases .", "label": "", "metadata": {}, "score": "57.813347"}
{"text": "Thus , screening interventions have a \" time lag to benefit .\" For patients with a life expectancy shorter than the time lag to benefit , cancer screening exposes this group to immediate risks with little chance that they would survive long enough to benefit .", "label": "", "metadata": {}, "score": "57.88871"}
{"text": "Screening for osteoporosis in postmenopausal women : recommendations and rationale .Ann Intern Med .Sheridan SL , Harris RP , Woolf SH .Shared decision making about screening and chemoprevention : a suggested approach from the U.S. Preventive Services Task Force .", "label": "", "metadata": {}, "score": "57.89086"}
{"text": "Breast Cancer .6 This study showed an increased invasive breast cancer incidence ( HR , 1.26 ; nominal 95 percent CI , 1.00 to 1.59 ) .", "label": "", "metadata": {}, "score": "57.901115"}
{"text": "[ PubMed ID : 15054679 ] .Chan AT , Giovannucci EL , Meyerhardt JA , et al .Long - term use of aspirin and nonsteroidal anti - inflammatory drugs and risk of colorectal cancer .", "label": "", "metadata": {}, "score": "58.026295"}
{"text": "Lung cancer mortality rates had similar patterns as incidence ( Table 3 ) .However , the mortality rate among white non - Hispanics was even lower in the Low SES counties , and a greater disparity was found in rates for the Intermediate and Low SES counties among Hispanics compared with the High SES counties .", "label": "", "metadata": {}, "score": "58.09121"}
{"text": "Cancer Epidemiol Biomarkers Prev 2008 ; 17 : 3108 - 3115 pmid : 18990751 Abstract .Tremendous progress has been made in recent years towards the understanding , prevention and management of malignant disease , yet cancer remains a leading cause of global mortality and morbidity .", "label": "", "metadata": {}, "score": "58.270393"}
{"text": "Lung cancer rates were substantially lower overall among Hispanics , and although their rates were higher in the Low and Intermediate SES counties , not much disparity was seen between rates from each group .", "label": "", "metadata": {}, "score": "58.540474"}
{"text": "Here , each of the studies included different histological types of breast carcinoma .Further analysis of fascin-1 in subtype - specific breast cancer is needed .", "label": "", "metadata": {}, "score": "58.6493"}
{"text": "Study reports a breast , endometrial , cervical , or colorectal cancer outcome of interest and was published on or after Jan. 1 , 2000 e .", "label": "", "metadata": {}, "score": "58.670677"}
{"text": "This is in addition to the beneficial effects of prevention of unwanted pregnancy .The likelihood that OC use decreases life expectancy is low , but there is insufficient evidence to estimate the overall effects on quality of life .", "label": "", "metadata": {}, "score": "58.709274"}
{"text": ", 1 : .Rodel C , Sauer R : Radiotherapy and concurrent radiochemotherapy for rectal cancer .Surg Oncol 2004 , 13 : 93 - 101 .", "label": "", "metadata": {}, "score": "58.819614"}
{"text": "When restricted to BRCA1 or BRCA2 carriers , the model predicted gains in women who used OCs of almost 10 months in BRCA1 carriers ( because of the much higher ovarian cancer risk ) and 1 month in BRCA2 carriers .", "label": "", "metadata": {}, "score": "58.947647"}
{"text": "Although prognostic markers are needed , the cornerstone to combating cancer now and in the future is by early diagnosis .Early diagnosis could result in the cure of many patients with cancer and in more effective treatments for the rest .", "label": "", "metadata": {}, "score": "59.024826"}
{"text": "For those outcomes included in the WHI \" global index \" that reached statistical significance , the absolute excess risk per 10,000 women - years in the group treated with CE - alone was 12 more strokes , while the absolute risk reduction per 10,000 women - years was 7 fewer hip fractures .", "label": "", "metadata": {}, "score": "59.05862"}
{"text": "To calculate cancer incidence and mortality rates for each category , the TCR used 2001 - 2005 county - specific incident cases of cancer and deaths with corresponding population data from the US Surveillance , Epidemiology , and End Results ( SEER ) program .", "label": "", "metadata": {}, "score": "59.068146"}
{"text": "Results were similar when restricted to five case - control studies and two cohort studies of ischemic stroke ( OR , 1.90 ; CI , 1.24 to 2.91 ) , but not for four case - control studies of hemorrhagic stroke ( OR , 1.03 ; CI , 0.71 to 1.49 ) .", "label": "", "metadata": {}, "score": "59.283356"}
{"text": "As for most diseases , the cause of cancer is multifactorial , meaning that many factors , both external ( eg , diet , tobacco , and radiation ) and internal ( eg , age , sex , and genetic make - up ) contribute to carcinogenesis .", "label": "", "metadata": {}, "score": "59.359997"}
{"text": "Pooling across all the included carcinomas in our dataset , we obtained strong evidence that fascin-1 is associated with increased risk of mortality , lymph node metastasis and distant metastasis .", "label": "", "metadata": {}, "score": "59.370346"}
{"text": "For all studies , the control and intervention cohorts were treated identically , with the same rates of overall all cause mortality and the same proportion of additional losses to follow - up .", "label": "", "metadata": {}, "score": "59.47485"}
{"text": "The incidence rates were slightly higher for Intermediate and Low SES counties compared with High SES counties in white non - Hispanics and Hispanics ( Table 2 ) .", "label": "", "metadata": {}, "score": "59.507854"}
{"text": "Conclusions and implications for practice guidelines .In this study , we have determined pooled estimates of the time lags to benefit for breast and colorectal cancer screening across a spectrum of absolute risk reduction thresholds .", "label": "", "metadata": {}, "score": "59.678417"}
{"text": "Comparable increases in breast cancer incidence were observed among women taking estrogen and progestin over 6.8 years of follow - up in HERS .9 The U.K. Million Women Study , a fair - quality study , showed an increased risk for breast cancer in current users of combined estrogen and progestin compared with those who had never used hormone therapy ( RR , 2.00 ; 95 percent CI , 1.91 to 2.09 ) .", "label": "", "metadata": {}, "score": "59.68496"}
{"text": "However , sensitivity analysis of studies that had provided a clear definition of cancer - specific mortality demonstrated that fascin-1 expression was associated with a 49 % increased risk of cancer - specific death .", "label": "", "metadata": {}, "score": "59.889397"}
{"text": "Statistical analysis .For our meta - analysis , we stratified the results by method of scoring ( that is , low versus high or positive versus negative ) and by type of carcinoma .", "label": "", "metadata": {}, "score": "60.058517"}
{"text": "Data from this report are meant to highlight possible gaps in cancer control measures and provide a basis to further investigate explanations for these disparities .", "label": "", "metadata": {}, "score": "60.131245"}
{"text": "No comparative effectiveness analyses have been conducted to inform decisions about the use of OCs as a primary preventive strategy for ovarian cancer .Scope and Key Questions .", "label": "", "metadata": {}, "score": "60.588165"}
{"text": "In a similar manner , for death from all causes , in participants with cancer , person - years of follow - up were calculated from the date of cancer diagnosis to either the date of death from any cause or the end of follow - up , whichever came first .", "label": "", "metadata": {}, "score": "60.6261"}
{"text": "We also evaluated benefits and harms of OC use that are not related to the development of ovarian cancer .Finally , we designed a comparative effectiveness model to inform the questions generated by this review .", "label": "", "metadata": {}, "score": "60.845055"}
{"text": "Rather , our results should inform individualized decision making , which aims to account for patient preferences and values while maximizing benefits and minimizing risks .", "label": "", "metadata": {}, "score": "60.949394"}
{"text": "Two studies [ 64 , 65 ] examined the association of fascin-1 positivity of carcinomas with lymph node metastasis , with a total of 147 lung carcinoma cases .", "label": "", "metadata": {}, "score": "60.99491"}
{"text": "Because limited life expectancy is predominantly a consideration for older adults , we excluded studies that focused solely on younger patients .We focused on calculating the number of years needed to reach various thresholds of benefit using the absolute risk reduction in cancer specific mortality .", "label": "", "metadata": {}, "score": "61.158794"}
{"text": "Breast Cancer - Females Breast cancer incidence rates were higher for each race and ethnicity in the Intermediate SES counties than in the High SES counties ( Table 2 ) .", "label": "", "metadata": {}, "score": "61.297966"}
{"text": "Roetzheim RG , Pal N , Tennant C , et al .Effects of health insurance and race on early detection of cancer .J Natl Cancer Inst .", "label": "", "metadata": {}, "score": "61.367695"}
{"text": "The observational epidemiologic data also reflect uncontrolled confounding by other factors ( e.g. , healthy diet ) .The bottom line for clinicians is that , for healthy women 45 to 64 years of age ( who represented 90 % of the participants in these 2 studies ) , there is no substantial benefit to long - term use of low - dose aspirin or high - dose vitamin E supplements .", "label": "", "metadata": {}, "score": "61.399605"}
{"text": "With survival curves for both the control and screened groups for each study , we calculated when specific absolute risk reduction thresholds were crossed in each study .", "label": "", "metadata": {}, "score": "61.586147"}
{"text": "Two studies [ 55 , 57 ] examined the association of fascin-1 positivity of carcinomas with distant metastasis , with a total of 314 gastric carcinoma cases .", "label": "", "metadata": {}, "score": "61.81671"}
{"text": "Further analyses of the association of fascin-1 with breast cancer mortality or metastasis will need to specifically evaluate different sub - types of breast carcinomas .", "label": "", "metadata": {}, "score": "61.83606"}
{"text": "diagnosis fascin-1 immunohistochemistry prognosis tumor markers .Background .According to current World Health Organization statistics , cancer accounts for approximately 7.6 million deaths per annum [ 1 ] .", "label": "", "metadata": {}, "score": "61.893898"}
{"text": "Cancer patients with diabetes experienced a rapid decline in survival within the first 3 years after cancer diagnosis ( Fig . 1 C ) .Overall , 69 % of participants with cancer died of cancer and 13 % died of circulatory disease .", "label": "", "metadata": {}, "score": "62.00782"}
{"text": "Conclusions Our results suggest that screening for breast and colorectal cancer is most appropriate for patients with a life expectancy greater than 10 years .Incorporating time lag estimates into screening guidelines would encourage a more explicit consideration of the risks and benefits of screening for breast and colorectal cancer .", "label": "", "metadata": {}, "score": "62.05065"}
{"text": "Applicability of the evidence to current U.S. practice is limited by several factors .Most importantly , the long duration between exposure to OCs and development of cancers means that the available evidence is based on a different distribution of OC formulations than are currently on the market .", "label": "", "metadata": {}, "score": "62.169987"}
{"text": "Six studies [ 19 , 21 , 50 - 53 ] examined the association of fascin-1 positivity with time - to - disease progression , with a total of 928 carcinoma cases .", "label": "", "metadata": {}, "score": "62.219276"}
{"text": "The association of fascin-1 with lymph node metastasis in colorectal , gastric , lung and esophageal carcinomas .In both A and B , squares indicate the study - specific effect estimate , with the size proportional to the inverse of the variance ( I - V ) ; horizontal lines show study - specific 95 % confidence intervals .", "label": "", "metadata": {}, "score": "62.231056"}
{"text": "Two studies [ 9 , 58 ] examined the association of high fascin-1 with distant metastasis and one [ 8 ] examined the association of fascin-1 positivity of carcinomas with distant metastasis , with a total of 516 esophageal carcinoma cases .", "label": "", "metadata": {}, "score": "62.365532"}
{"text": "Cancer .Halpern MT , Ward EM , Pavluck AL , Schrag NM , Bian J , Chen AY .Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites : a retrospective analysis .", "label": "", "metadata": {}, "score": "62.741993"}
{"text": "However , this small chance of benefit must be weighed against the chance of patients being harmed from screening .For colorectal cancer screening , systematic reviews suggest that about one in 10 patients who are screened with fecal occult blood testing will have a false positive result , 36 leading to worry and colonoscopy .", "label": "", "metadata": {}, "score": "62.80512"}
{"text": "The use of estrogen alone may lead to increased risk for thromboembolism , stroke , dementia , and lower global cognitive function .The evidence is insufficient to determine the effects of unopposed estrogen on the incidence of breast cancer , ovarian cancer , colorectal cancer , breast cancer mortality , or all - cause mortality .", "label": "", "metadata": {}, "score": "62.94349"}
{"text": "KQ 5 : What are the harms of OC use , including breast cancer incidence , cervical cancer incidence , venous thromboembolic disease , stroke , or myocardial infarction ?", "label": "", "metadata": {}, "score": "63.027084"}
{"text": "Methods .Inclusion and exclusion criteria .A systematic review of all published literature on the association of fascin-1 protein expression with carcinoma progression in breast , colorectal , gastric , lung and esophageal carcinomas was carried out .", "label": "", "metadata": {}, "score": "63.0394"}
{"text": "However , given the morbidity associated with surgery , and the potential effects of early menopause , this is not considered a reasonable option for the general population .", "label": "", "metadata": {}, "score": "63.061207"}
{"text": "However , women who have lumpectomy alone , without further treatment , are at higher risk of developing invasive breast cancer in the same breast .", "label": "", "metadata": {}, "score": "63.09427"}
{"text": "We suspect a possible reason that we generally found the highest incidence and mortality rates among the Intermediate SES group versus the Low SES group is due to misclassification of SES level .", "label": "", "metadata": {}, "score": "63.165077"}
{"text": "Different clinicians and patients might have differing perspectives on the probability of future mortality benefit that justifies the immediate risks and burdens of screening .Therefore , we presented a spectrum of time lags to benefit , corresponding to varying specific thresholds of absolute risk reduction .", "label": "", "metadata": {}, "score": "63.36438"}
{"text": "Mortality from myocardial infarction .Current vs. noncurrent use / never .3 ( 46,112 women plus 3,091,673 person - years ) .Medium .Inconsistent .", "label": "", "metadata": {}, "score": "63.413437"}
{"text": "To estimate a pooled time lag to benefit across trials , we extracted survival curves for the control and intervention groups for each study before combining the survival curves in our meta - analysis to obtain pooled estimates of absolute risk reduction .", "label": "", "metadata": {}, "score": "63.435482"}
{"text": "Imprecise .Low 0.85 ( 0.67 to 1.07 ) .Key Question 6 .Decision Analysis : Benefits and Harms of OC Use and Ovarian Cancer Risk .", "label": "", "metadata": {}, "score": "63.461754"}
{"text": "Thirdly , our study focused on cause specific mortality that could have been subject to ascertainment bias , owing to late or unexpected complications of screening or treatment not considered in rates of cause specific mortality .", "label": "", "metadata": {}, "score": "63.66047"}
{"text": "View Article .Sarrio D , Rodriguez - Pinilla SM , Hardisson D , Cano A , Moreno - Bueno G , Palacios J : Epithelial - mesenchymal transition in breast cancer relates to the basal - like phenotype .", "label": "", "metadata": {}, "score": "63.661896"}
{"text": "Predictions of the long - term effects of OC use are necessarily based on population - based , age - specific incidence and mortality data .", "label": "", "metadata": {}, "score": "63.67961"}
{"text": "A total of 26 immunohistochemical studies of 5 prevalent human carcinomas were identified for meta - analysis .There was no evidence of association of fascin-1 with mortality in gastric and lung carcinomas .", "label": "", "metadata": {}, "score": "63.74838"}
{"text": "Additional research is needed to determine if other explanations can account for this uncharacteristic result .Multiple explanations may be offered for the differences in cancer rates seen among SES groups .", "label": "", "metadata": {}, "score": "63.843155"}
{"text": "The estrogen - only arm of the WHI trial showed no decreased risk for CHD .Stroke .14 , 15 The risk for subarachnoid bleeding and hemorrhagic stroke was not increased , and the overall stroke mortality was marginally reduced ( RR , 0.81 ; 95 percent CI , 0.71 to 0.92 ) .", "label": "", "metadata": {}, "score": "63.898987"}
{"text": "The benefits include reduced risk for fracture ( good evidence ) .Harms include increased risk for venous thromboembolism ( fair evidence ) , stroke ( fair evidence ) , dementia ( fair evidence ) , and lowered global cognitive functioning ( fair evidence ) .", "label": "", "metadata": {}, "score": "63.912094"}
{"text": "We determined the annual number of cancer deaths by multiplying the annual risk of cause specific mortality by the annual number at risk .The annual number at risk was determined using the initial sample size and the total person years of observation in the screening and control cohorts .", "label": "", "metadata": {}, "score": "63.916367"}
{"text": "The pattern of mortality rates by race and ethnicity for each SES group is similar to incidence , with the exception that mortality rates in white non - Hispanics were lowest in the Low SES counties ( Table 3 ) [ PDF ] .", "label": "", "metadata": {}, "score": "64.08232"}
{"text": "Women with a family history of ovarian or premenopausal breast cancer , suggesting increased risk according to current recommendations .Women with a known BRCA1/BRCA2 mutation .", "label": "", "metadata": {}, "score": "64.11415"}
{"text": "Recently , we commented on the failure of many new cancer biomarkers to reach the clinic [ 8 ] .We grouped the failures into three categories : fraudulent reports , true discoveries that fail to meet the demands of the clinic ; and false discoveries .", "label": "", "metadata": {}, "score": "64.19095"}
{"text": "Biomarkers have a pivotal role in cancer screening , diagnosis , prognosis and therapeutic monitoring .Since tumor metastasis remains a major cause of cancer mortality , there is a compelling need for the discovery and validation of novel biomarkers for early characterization of carcinomas by their aggressive potential [ 1 ] .", "label": "", "metadata": {}, "score": "64.27812"}
{"text": "PubMed View Article .Minn AJ , Gupta GP , Siegel PM , Bos PD , Shu W , Giri DD , Viale A , Olshen AB , Gerald WL , Massague J : Genes that mediate breast cancer metastasis to lung .", "label": "", "metadata": {}, "score": "64.32033"}
{"text": "An important role of hyperinsulinemia in colorectal and pancreatic carcinogenesis is supported by in vitro studies , animal models , and several epidemiologic studies ( 14 ) .", "label": "", "metadata": {}, "score": "64.6251"}
{"text": "The association of fascin-1 with disease progression in breast , colorectal and lung carcinomas .Squares indicate the study - specific effect estimate , with the size proportional to the inverse of the variance ( I - V ) ; horizontal lines show study - specific 95 % confidence intervals .", "label": "", "metadata": {}, "score": "64.66406"}
{"text": "We emailed trial authors to request data for annual cancer mortality and annual numbers at risk .Two colorectal cancer trials ( Nottingham and Goteborg ) and one breast cancer trial ( Two - County : Ostergotland ) provided these data .", "label": "", "metadata": {}, "score": "64.69607"}
{"text": "PubMed View Article .Friedenberg F , Fernandez A , Sorondo B , Fazili J , Braitman L : The proximal shift in the distribution of colon cancer is independent of age and gender .", "label": "", "metadata": {}, "score": "64.73416"}
{"text": "Ward E , Halpern M , Schrag N , et al .Association of insurance with cancer care utilization and outcomes .CA Cancer J Clin .", "label": "", "metadata": {}, "score": "64.77871"}
{"text": "The role of chemopreventive agents in preventing fractures in women without low bone density is unclear .The USPSTF addressed screening for osteoporosis in postmenopausal women in 2002 .", "label": "", "metadata": {}, "score": "64.90234"}
{"text": "Fourthly , we relied on older studies of cancer screening that could have limited our ability to address current strategies of cancer screening .For breast cancer screening , modern mammography machines could be more accurate , and radiologists might now receive better training .", "label": "", "metadata": {}, "score": "64.969795"}
{"text": "One study reported that fascin-1 immuno - staining was more common in adenocarcinomas with prevalent invasive components of the acinar , papillary and solid types compared to adenocarcinomas with a prevalent bronchiolo - alveolar component [ 50 ] .", "label": "", "metadata": {}, "score": "64.980736"}
{"text": "Both analyses showed similar reductions in ovarian cancer risk with OC use independent of BRCA carrier status or gravidity / parity .Three case - control studies , one of good quality and two of fair quality , were identified that examined the effect of family history on the association between OC use and ovarian cancer .", "label": "", "metadata": {}, "score": "64.99227"}
{"text": "To exclude ethnicity and locality as modifying factors , more studies should be carried out to assess the association between fascin-1 and risk of esophageal cancer - specific mortality in Western countries .", "label": "", "metadata": {}, "score": "65.00266"}
{"text": "Breast cancer screening .For breast cancer screening , we started with the USPSTF meta - analyses conducted in 2002 , 10 the Cochrane Collaboration review in 2009 , 9 and the USPSTF review in 2009 .", "label": "", "metadata": {}, "score": "65.07774"}
{"text": "Noncardiovascular disease outcomes during 6.8 years of hormone therapy : Heart and estrogen / progestin replacement study follow - up ( HERS II ) .JAMA .", "label": "", "metadata": {}, "score": "65.42759"}
{"text": "Miller AB , To T , Baines CJ , Wall C. The Canadian National Breast Screening Study-1 : breast cancer mortality after 11 to 16 years of follow - up .", "label": "", "metadata": {}, "score": "65.50931"}
{"text": "This is one in a series excerpted from the Recommendation Statements released by the U.S. Preventive Services Task Force ( USPSTF ) .These statements address preventive health services for use in primary care clinical settings , including screening tests , counseling , and chemoprevention .", "label": "", "metadata": {}, "score": "65.544586"}
{"text": "Sensitivity analysis .The analysis of all carcinomas indicated an association of fascin-1 with increased risk of mortality .However , not all studies had provided a clear definition of the cause of death .", "label": "", "metadata": {}, "score": "65.55451"}
{"text": "Other strengths of our study include a community - based cohort , comprehensive ascertainments of cancer and mortality , data on potential confounders , and 17 years of follow - up that offered the opportunity to study long - term associations .", "label": "", "metadata": {}, "score": "65.69294"}
{"text": "4 - 6 In addition , we find substantial differences in access to health care , including lack of health insurance and access to physicians and health care facilities .", "label": "", "metadata": {}, "score": "65.707115"}
{"text": "Timing of the initiation of estrogen plus progestin therapy relative to the start of menopause may affect the overall risk benefit profile .The WHI estrogen plus progestin substudy stratified for age showed in women 50 to 59 years of age a non - significant trend toward reduced risk for overall mortality [ HR 0.69 ( 95 percent CI , 0.44 - 1.07)].", "label": "", "metadata": {}, "score": "65.87372"}
{"text": "For this report , we applied an ecologic methodology to assess SES differences in cancer among Texas residents .We examined the rates separately for white non - Hispanics , blacks , and Hispanics and considered five cancer sites and all cancer sites collected by the TCR combined in relation to a single measure of SES , the percentage of persons below the federal poverty level .", "label": "", "metadata": {}, "score": "65.875565"}
{"text": "Outcomes .Study reports quantitative association between exposure to OCs and one of the outcomes listed below : .KQs 1 , 2 , 3 , 6 : .", "label": "", "metadata": {}, "score": "65.89067"}
{"text": "Several studies [ 13 , 15 - 17 ] have investigated the clinical relevance of fascin-1 mRNA levels in tumor tissues .For breast carcinomas , it was reported that high fascin-1 mRNA levels were associated with a lung metastasis signature [ 16 ] and decreased overall and metastasis- free survival [ 13 ] .", "label": "", "metadata": {}, "score": "65.9195"}
{"text": "There are few available data on patient preferences relevant to the use of OCs as primary prevention .Better data on the relative quality - of - life effects of regular OC use , and the outcomes we reviewed here , would allow for better assessment of the overall tradeoffs between harms and benefits at both the individual and population level .", "label": "", "metadata": {}, "score": "66.05253"}
{"text": "Five major cancer types were examined for their association to four clinical outcomes .This study raises a number of important questions regarding fascin-1 .First , the pathophysiology of fascin-1 needs to be further elucidated as it is unclear how fascin-1 could be associated with an increased risk of both lymph node positivity and distant metastasis in gastric cancer but have no association with mortality .", "label": "", "metadata": {}, "score": "66.26604"}
{"text": "Key Question 3 .Relative Risk of Ovarian Cancer in OC Users in Subpopulations .BRCA1 and BRCA2 carriers ( 4 studies [ 1 good quality and 1 fair quality ] : 3 were case - control studies with 1,096 cases and 2,878 controls , and 1 was a cohort study with 3,181 participants ) .", "label": "", "metadata": {}, "score": "66.27304"}
{"text": "Finally , our sample was almost entirely white ; generalizability to nonwhite populations warrants further investigation .Our study suggests that for many common cancers like colon , breast , and prostate , diabetes exerts a stronger adverse influence downstream , after cancer occurs , than upstream , in relation to incident cancer risk .", "label": "", "metadata": {}, "score": "66.32498"}
{"text": "For mortality , rates were unstable for blacks in High and Low SES counties because very few deaths occurred ( 11 and 13 , respectively ) .", "label": "", "metadata": {}, "score": "66.34862"}
{"text": "Stata Statistical Software : release 11.2 .StataCorp LP ; College Station , TX , USA ) to calculate a summary hazard ratio ( HR ) for mortality and time - to - disease progression outcomes or a summary risk ratio ( RR ) for lymph node and distant metastasis outcomes .", "label": "", "metadata": {}, "score": "66.359695"}
{"text": "Further , certain comorbidities such as dementia could increase the risks of screening ; for these patients , the higher immediate risks suggest that the absolute risk reduction must also be higher for cancer screening to be beneficial .", "label": "", "metadata": {}, "score": "66.41655"}
{"text": "The estrogen - only arm of the WHI trial showed neither benefit nor harm for colorectal cancer risk ( HR , 1.08 ; adjusted 95 percent CI , 0.63 to 1.86 ) .", "label": "", "metadata": {}, "score": "66.60193"}
{"text": "The magnitude of the association between OC use and breast cancer was similar in BRCA1 and BRCA2 carriers , although confidence intervals included 1 .The overall strength of evidence is reduced because of the risk of bias in observational studies .", "label": "", "metadata": {}, "score": "66.78632"}
{"text": "What is already known on this topic .Guidelines recommend targeting cancer screening to healthier older patients ; the complications from screening can harm patients immediately , while the benefits are not seen for many years .", "label": "", "metadata": {}, "score": "66.90346"}
{"text": "Br J Cancer 2003 , 88 : 537 - 547 .PubMed View Article .Oh SY , Kim YB , Suh KW , Paek OJ , Moon HY : Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer .", "label": "", "metadata": {}, "score": "67.003876"}
{"text": "They found that the development of invasive ipsilateral breast cancer was associated with death rates that were statistically significantly higher than those in women who did not develop an invasive ipsilateral breast cancer .", "label": "", "metadata": {}, "score": "67.1657"}
{"text": "N Engl J Med .[ PubMed ID : 15753114 ] .Asano TK , McLeod RS .Nonsteroidal anti - inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer : a systematic review .", "label": "", "metadata": {}, "score": "67.22644"}
{"text": "Finally , our meta - analysis could have obscured real differences in the time lag to benefit from different testing methods ( for example , rehydrated v unrehydrated fecal occult blood testing ) , testing frequencies ( for example , annual v biennial ) , and populations .", "label": "", "metadata": {}, "score": "67.36299"}
{"text": "The overall impact on net harms and benefits of progestin - only pills , particularly for vascular events , is potentially better than for combination pills .", "label": "", "metadata": {}, "score": "67.40111"}
{"text": "The remaining studies were retrospective in design using samples based on the availability of specimens with interpretable cores ( which may have been non - random ) and clinical histories , rather than specifying and recruiting a truly representative sample from a clearly defined target population .", "label": "", "metadata": {}, "score": "67.42906"}
{"text": "Poor : .Evidence is insufficient to assess the effects on health outcomes because of limited number or power of studies , important flaws in their design or conduct , gaps in the chain of evidence , or lack of information on important health outcomes .", "label": "", "metadata": {}, "score": "67.66396"}
{"text": "Poor : .Evidence is insufficient to assess the effects on health outcomes because of limited number or power of studies , important flaws in their design or conduct , gaps in the chain of evidence , or lack of information on important health outcomes .", "label": "", "metadata": {}, "score": "67.66396"}
{"text": "There was no difference between the groups in terms of all - cause mortality .No overall difference for primary CHD events ( nonfatal MI , silent MI and CHD death ) and invasive breast cancer incidence in women receiving CE - alone compared to placebo was reported in final centrally adjudicated results from the estrogen - alone substudy , after an average follow - up of 7.1 years .", "label": "", "metadata": {}, "score": "67.6776"}
{"text": "PubMed View Article .Smith RA , Tang J , Tudur - Smith C , Neoptolemos JP , Ghaneh P : Meta - analysis of immunohistochemical prognostic markers in resected pancreatic cancer .", "label": "", "metadata": {}, "score": "67.704765"}
{"text": "There is consistent evidence from a variety of sources that oral contraceptive ( OC ) use reduces ovarian cancer risk .This evidence includes declining age - specific ovarian cancer incidence and mortality in cohorts of women who had access to OCs throughout their reproductive life , and there are several biologically plausible mechanisms for a protective effect .", "label": "", "metadata": {}, "score": "67.71371"}
{"text": "CA Cancer J Clin 2013 , 63 : 11 - 30 .PubMed View Article .Etzioni R , Urban N , Ramsey S , McIntosh M , Schwartz S , Reid B , Radich J , Anderson G , Hartwell L : The case for early detection .", "label": "", "metadata": {}, "score": "67.76503"}
{"text": "Jackson RD , et al .Effects of Conjugated Equine Estrogen on Risk of Fractures and BMD in Postmenopausal Women With Hysterectomy : Results From the Women 's Health Initiative Randomized Trial .", "label": "", "metadata": {}, "score": "67.80007"}
{"text": "This could be expected due to the biological differences in mechanisms of carcinoma progression for different organs .For example , the weak association between fascin-1 and metastasis in esophageal carcinomas could be due to the rapid progression to metastatic disease that occurs in most patients with esophageal carcinoma .", "label": "", "metadata": {}, "score": "67.803"}
{"text": "6 ( In its analysis , the USPSTF used nominal 95 percent CIs for the primary outcomes and adjusted 95 percent CIs for all secondary outcomes . )", "label": "", "metadata": {}, "score": "67.91826"}
{"text": "Singh GK , Siahpush M. All - cause and cause - specific mortality of immigrants and native born in the United States .Am J Public Health .", "label": "", "metadata": {}, "score": "68.00985"}
{"text": "Many of the largest and most complete studies were performed outside of the United States .Differences in formulations , in prevalence of genetic and acquired factors affecting outcome risk , and in health - system characteristics , such as population coverage for cancer screening , may affect study results .", "label": "", "metadata": {}, "score": "68.10217"}
{"text": "However , this new test could also lead to more false positive results , making its ultimate effect on colorectal cancer mortality unclear .Furthermore , three studies of screening flexible sigmoidoscopy have been published since 2009 , which we were unable to incorporate owing to a lack of published survival curves 41 and Cochrane or USPSTForce reviews on study quality .", "label": "", "metadata": {}, "score": "68.11113"}
{"text": "This was a major barrier to evidence synthesis , particularly since the model results showed that differences in assumptions about how these factors affect the association between OC use and outcomes can alter the overall balance of harms and benefits .", "label": "", "metadata": {}, "score": "68.177155"}
{"text": "Prostate Cancer Overall , prostate cancer incidence and mortality rates were significantly higher among blacks .By SES , prostate cancer incidence rates were highest in the Intermediate SES counties for white non - Hispanics and blacks , but very little difference in rates was seen when Low SES counties were compared with High SES counties ( Table 2 ) .", "label": "", "metadata": {}, "score": "68.180756"}
{"text": "The WHI estrogen plus progestin substudy was stopped early .According to the predefined stopping rule , after an average follow - up of 5.6 years of treatment , the increased risk of invasive breast cancer and cardiovascular events exceeded the specified benefits included in the \" global index \" .", "label": "", "metadata": {}, "score": "68.222305"}
{"text": "Population .All KQs : .Women taking OCs for contraception or women taking OCs for primary prevention of ovarian cancer a .Women who do not have a history of ovarian cancer and have not undergone bilateral oophorectomy .", "label": "", "metadata": {}, "score": "68.338196"}
{"text": "6 The estrogen - only arm of the WHI trial , which was terminated after an average of 6.8 years of follow - up , showed a trend toward increased stroke risk with unopposed estrogen use ( HR , 1.39 ; adjusted 95 percent CI , 0.97 to 1.99 ) .", "label": "", "metadata": {}, "score": "68.34698"}
{"text": "Other baseline variables .Clinical variables , including resting blood pressure and plasma total cholesterol , were measured for each participant .A follow - up questionnaire in 1996 ascertained whether participants had a first - degree family history of cancer .", "label": "", "metadata": {}, "score": "68.3662"}
{"text": "Between these extremes is an intermediate zone of small or unclear benefit , 38 in which patient preferences and values should have the dominant role in deciding whether screening is appropriate .", "label": "", "metadata": {}, "score": "68.386246"}
{"text": "The finding that \u03b1 - tocopherol supplements had no benefit or might even increase mortality ( 4 ) is at odds with well - established epidemiologic data regarding diets high in vitamin E , including \u03b1 - tocopherol and other antioxidants .", "label": "", "metadata": {}, "score": "68.38785"}
{"text": "We subsequently excluded cancer incidence and cancer death in the first 2 years of follow - up to minimize the potential that participants may have had subclinical cancer prior to baseline .", "label": "", "metadata": {}, "score": "68.495285"}
{"text": "Recommendations of Other Groups .The American College of Obstetricians and Gynecologists , 27 American Heart Association , 28 North American Menopause Society , 29 and Canadian Task Force on Preventive Health Care 30 , 31 recommend against use of hormone therapy for the prevention of chronic diseases in postmenopausal women .", "label": "", "metadata": {}, "score": "68.49917"}
{"text": "Singh GK , Miller BA , Hankey BF , Feuer EJ , Pickle LW .Changing area socioeconomic patterns in U.S. cancer mortality , 1950 - 1998 : Part I - All cancers among men .", "label": "", "metadata": {}, "score": "68.55082"}
{"text": "Key Question 4 .Other Benefits of OC Use .Colorectal Cancer .Table C shows the strength of evidence for the effect of OC use on colorectal cancer .", "label": "", "metadata": {}, "score": "68.598434"}
{"text": "However , the TCR does collect the address at the time of diagnosis , and measures of SES at the population level are captured by the US Census Bureau .", "label": "", "metadata": {}, "score": "68.616135"}
{"text": "Table D shows the strength of evidence for the effect of OC use on endometrial cancer .OC use significantly reduced the incidence of endometrial cancer ( OR , 0.58 ; 95 % CI , 0.45 to 0.73 ) .", "label": "", "metadata": {}, "score": "68.6696"}
{"text": "-EHC019-EF .Full Report .Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer .Evidence Report / Technology Assessment No . 212 .", "label": "", "metadata": {}, "score": "68.697075"}
{"text": "Among white non - Hispanics , we found little difference in mortality rates by SES .For blacks and Hispanics , mortality rates increased with decreasing SES ( Table 3 ) but were not statistically different from High SES counties .", "label": "", "metadata": {}, "score": "68.71101"}
{"text": "6 However , mortality from CHD was not significantly increased among the women taking combined hormone therapy daily .14 This meta - analysis also showed that CHD mortality in observational studies was reduced among current hormone therapy users ( RR , 0.62 ; 95 percent CI , 0.40 to 0.90 ) but was not reduced among those who had used hormone therapy in the past .", "label": "", "metadata": {}, "score": "68.86957"}
{"text": "We found that published data for the total person years of observation was lower than our calculated total , suggesting additional losses to follow - up .", "label": "", "metadata": {}, "score": "68.94433"}
{"text": "Since the ancillary study was conducted in women 65 to 79 years of age , it is unknown whether these findings apply to younger postmenopausal women [ see WARNINGS AND PRECAUTIONS , and Use in Specific Populations ] .", "label": "", "metadata": {}, "score": "69.00658"}
{"text": "Anderson GL , Limacher M , Assaf AR , Bassford T , Beresford SA , Black H , et al .Effects of conjugated equine estrogen in postmenopausal women with hysterectomy : the Women 's Health Initiative randomized controlled trial .", "label": "", "metadata": {}, "score": "69.14836"}
{"text": "[ 61 ] was excluded from the analysis as it had presented two - year mortality rates for each fascin-1 category , and we could not estimate hazard ratios .", "label": "", "metadata": {}, "score": "69.36655"}
{"text": "Since the ancillary study was conducted in women 65 to 79 years of age , it is unknown whether these findings apply to younger postmenopausal women [ see WARNINGS AND PRECAUTIONS and Use In Specific Populations ] .", "label": "", "metadata": {}, "score": "69.49382"}
{"text": "For the 18 studies examining associations of fascin-1 with mortality , only 8 studies , [ 6 , 7 , 9 , 24 , 52 , 55 , 56 , 58 ] , were found to be of high methodological quality .", "label": "", "metadata": {}, "score": "69.517075"}
{"text": "Bethesda , MD : National Cancer Institute .Wallace AH , Havrilesky LJ , Valea FA , et al .Projecting the need for gynecologic oncologists for the next 40 years .", "label": "", "metadata": {}, "score": "69.82826"}
{"text": "PubMed View Article .Tan VY , Lewis SJ , Adams JC , Martin RM :Association of fascin-1 with mortality , disease progression and metastasis in carcinomas : a systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "69.89934"}
{"text": "CONCLUSIONS .This community - based , prospective study provides support for the following conclusions .First , adults with treated diabetes were more likely to develop cancer than their nondiabetic counterparts , especially pancreatic cancer .", "label": "", "metadata": {}, "score": "69.98829"}
{"text": "40 As a result , previous meta - analyses of breast and colorectal cancer screening showed no differences in all cause mortality between screened and unscreened groups .", "label": "", "metadata": {}, "score": "70.01753"}
{"text": "AHRQ publication no 08 - 05124-EF-1 .Agency for Healthcare Research and Quality , October 2008:1 - 88 .Hewitson P , Glasziou P , Watson E , Towler B , Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test ( hemoccult ) : an update .", "label": "", "metadata": {}, "score": "70.03436"}
{"text": "Strength of evidence domains for the effect of OC use on ovarian cancer .Effect .Comparison .Number of Studies ( Women and/or Person - Years ) .", "label": "", "metadata": {}, "score": "70.10689"}
{"text": "Combined estrogen and progestin may reduce the risk for fractures and colorectal cancer , but it has no beneficial effect on CHD .The use of combined estrogen and progestin may lead to increased risk for breast cancer , venous thromboembolism , stroke , cholecystitis , dementia , and lower global cognitive function .", "label": "", "metadata": {}, "score": "70.10976"}
{"text": "Effectiveness of OC Use for Reducing Incidence of Ovarian Cancer .Table B shows the strength of evidence for the effect of OC use on ovarian cancer .", "label": "", "metadata": {}, "score": "70.20178"}
{"text": "People at a lower SES tend to have poorer access to health care , lower educational levels , and a higher prevalence of many unhealthy behaviors .", "label": "", "metadata": {}, "score": "70.22238"}
{"text": "There is insufficient evidence to recommend for or against the use of OCs solely for the primary prevention of ovarian cancer .References .Altekruse SF , Kosary CL , Krapcho M , et al .", "label": "", "metadata": {}, "score": "70.40169"}
{"text": "Overall mortality c , d .Global Index g . a Adapted from numerous WHI publications .b Nominal confidence intervals unadjusted for multiple looks and multiple comparisons .", "label": "", "metadata": {}, "score": "70.44325"}
{"text": "Although results were consistent , direct , and precise for ever use versus never use and for duration of use , strength of evidence was moderate because of the persistent risk of bias due to the observational nature of the studies .", "label": "", "metadata": {}, "score": "70.48041"}
{"text": "If separate data for immunoreactivity or intensity scores were given , we chose to extract the immunoreactivity scores .This is because a recent study [ 24 ] showed that immunoreactivity scores alone are a sufficient measure for estimating the association of fascin-1 with mortality .", "label": "", "metadata": {}, "score": "70.51724"}
{"text": "In both A and B , squares indicate the study - specific effect estimate , with the size proportional to the inverse of the variance ( I - V ) ; horizontal lines show study - specific 95 % confidence intervals .", "label": "", "metadata": {}, "score": "70.594635"}
{"text": "All the studies in our dataset had analyzed only non - small cell lung carcinomas , which include both squamous cell carcinomas and adenocarcinomas .Patients with pulmonary squamous cell carcinoma have a higher mortality rate than those with adenocarcinomas , which might be attributable to confounding factors , such as smoking status and age - related co - morbidities [ 78 , 79 ] .", "label": "", "metadata": {}, "score": "70.73241"}
{"text": "Br J Cancer 2009 , 101 : 1124 - 1129 .PubMed View Article .Hashimoto Y , Skacel M , Lavery IC , Mukherjee AL , Casey G , Adams JC : Prognostic significance of fascin expression in advanced colorectal cancer : an mmunohistochemical study of colorectal adenomas and adenocarcinomas .", "label": "", "metadata": {}, "score": "70.768524"}
{"text": "Metastasis is the major source of cancer - related mortality and , at the cellular level , a major effect of fascin-1 is in promoting carcinoma cell migration and invasion .", "label": "", "metadata": {}, "score": "70.78859"}
{"text": "In addition , there was limited control for confounding in the analysis of most datasets and incomplete ascertainment of outcome data , due to loss to follow - up , which can lead to biased effect - estimates .", "label": "", "metadata": {}, "score": "70.86913"}
{"text": "Randomized controlled trials of screening have focused on the magnitude of benefit rather than when those benefits occur , leading to varying recommendations about the time lag to benefit .", "label": "", "metadata": {}, "score": "70.98943"}
{"text": "The estrogen - only arm of the WHI trial showed a trend toward increased risk for venous thromboembolism with unopposed estrogen use ( HR , 1.33 ; adjusted 95 percent CI , 0.86 to 2.08 ) .", "label": "", "metadata": {}, "score": "71.07579"}
{"text": "To indicate the summary judgment of the quality for the individual studies , we used the summary ratings of good , fair , and poor .", "label": "", "metadata": {}, "score": "71.07614"}
{"text": "Fascin-1 is correlated with increased risk of disease progression in breast and colorectal carcinomas , but not in lung carcinoma .Strong evidence for association of fascin-1 with increased risk of lymph node metastasis was found for colorectal and gastric carcinomas , but not for lung and esophageal carcinomas .", "label": "", "metadata": {}, "score": "71.15846"}
{"text": "Radiation treatment after lumpectomy reduced the risk of ipsilateral invasive breast cancer compared to lumpectomy alone , and treatment with radiation and tamoxifen reduced the risk compared to radiation only .", "label": "", "metadata": {}, "score": "71.23461"}
{"text": "Ferlay J , Shin HR , Bray F , Forman D , Mathers C , Parkin DM : GLOBOCAN 2008 v2.0 , Cancer Incidence and Mortality Worldwide : IARC CancerBase No . 10 .", "label": "", "metadata": {}, "score": "71.25231"}
{"text": "Firstly , since all trials examined multiple rounds of screening , we focused on the time lag to benefit for multiple rounds of screening .However , the patient and provider must make the decision to undergo ( or forego ) a screening test .", "label": "", "metadata": {}, "score": "71.29445"}
{"text": "Updated mortality results and new insights from long - term follow - up .Radiol Clin North Am 2000 ; 38 : 625 -51 .Scholefield JH , Moss S , Sufi F , Mangham CM , Hardcastle JD .", "label": "", "metadata": {}, "score": "71.32825"}
{"text": "Question .Methods .Design : Randomized placebo - controlled trial ( Women 's Health Study [ WHS ] , a randomized 2 \u00d7 2 factorial trial ) .", "label": "", "metadata": {}, "score": "71.35505"}
{"text": "To compare the impact of diabetes across the full range of cancer outcomes , we calculated a series of AFs ( Fig . 1 D ) .", "label": "", "metadata": {}, "score": "71.38309"}
{"text": "Mortality from VTE .Current vs. noncurrent use / never .NA .NA .NA .NA .Insufficient NA .Stroke .Table H shows the strength of evidence for the effect of OC use on stroke .", "label": "", "metadata": {}, "score": "71.39767"}
{"text": "Women 's Health Initiative Studies .The WHI enrolled approximately 27,000 predominantly healthy postmenopausal women in two substudies to assess the risks and benefits of daily oral CE ( 0.625 mg)-alone or in combination with MPA ( 2.5 mg ) compared to placebo in the prevention of certain chronic diseases .", "label": "", "metadata": {}, "score": "71.41177"}
{"text": "This result suggested that Weibull curves were an appropriate modeling strategy for our data .For each study , we truncated the Weibull curves at the maximum follow - up time so that estimates of longer times to benefit were based on fewer studies .", "label": "", "metadata": {}, "score": "71.48743"}
{"text": "Each section also assesses potential modifying factors such as dose , formulation , and duration of OC use , and considers specific evidence gaps and needs for future research regarding the association between OC use and the specific outcomes ( KQ 7 ) .", "label": "", "metadata": {}, "score": "71.538025"}
{"text": "We investigated for the potential presence of publication bias through visual inspection of funnel plot asymmetry and by computation of Egger 's test .For the mortality , time - to - disease progression and distant metastasis outcomes , data points in the funnel plot analyses approximated a symmetrical distribution indicating that publication bias is unlikely to be present in our analyses ( Figure 6 ) .", "label": "", "metadata": {}, "score": "71.53932"}
{"text": "Abstract .Objectives To determine a pooled , quantitative estimate of the length of time needed after breast or colorectal cancer screening before a survival benefit is observed .", "label": "", "metadata": {}, "score": "71.55795"}
{"text": "Evidence review update no 74 , publication no 10 - 05142-EF-1 .Agency for Healthcare Research and Quality , 2009:1 - 89 .Hoff G , Grotmol T , Skovlund E , Bretthauer M ; Norwegian Colorectal Cancer Prevention Study Group .", "label": "", "metadata": {}, "score": "71.7369"}
{"text": "Thus , it may be hard to apply these results to older women .Subgroup analysis suggested a benefit in the older age group with both vitamin E and low - dose aspirin ( 1 ) in the prevention of CVD .", "label": "", "metadata": {}, "score": "71.77057"}
{"text": "Differences between groups became apparent in the first year of treatment .It is unknown whether these findings apply to younger postmenopausal women [ see WARNINGS AND PRECAUTIONS , and Use in Specific Populations .", "label": "", "metadata": {}, "score": "71.81117"}
{"text": "Persson I , Yuen J , Bergkvist L , Schairer C. Cancer incidence and mortality in women receiving estrogen and estrogen - progestin replacement therapy - long - term follow - up of a Swedish cohort .", "label": "", "metadata": {}, "score": "71.898125"}
{"text": "Overall , the harmful effects of combined estrogen and progestin are likely to exceed the benefits of chronic disease prevention for most women .Unopposed estrogen increases a woman 's risk for endometrial cancer ; however , it has been used in postmenopausal women without a uterus to prevent chronic disease .", "label": "", "metadata": {}, "score": "72.24956"}
{"text": "Rossouw JE , Anderson GL , Prentice RL , LaCroix AZ , Kooperberg C , Stafanick ML , et al .Risks and benefits of estrogen plus progestin in healthy postmenopausal women : principal results from the Women 's Health Initiative randomized controlled trial .", "label": "", "metadata": {}, "score": "72.37457"}
{"text": "If OC use does significantly affect the incidence of certain cancers , then predictions of the long - term impact of prescribing OCs today will be in error .", "label": "", "metadata": {}, "score": "72.522"}
{"text": "ScienceDaily , 20 June 2011 . . .Journal of the National Cancer Institute .( 2011 , June 20 ) .DCIS patients who get invasive breast cancer have higher mortality , study finds .", "label": "", "metadata": {}, "score": "72.557785"}
{"text": "For all - cause mortality , we identified deaths among cohort members via searches of the National Death Index , Maryland death certificates , reviews of obituaries of the local newspaper , and reports by next of kin .", "label": "", "metadata": {}, "score": "72.58214"}
{"text": "To determine the time lag to benefit , we calculated the time at which specific thresholds of absolute risk reduction ( 1:10 000 , 1:5000 , 1:2000 , 1:1000 , 1:500 ) were crossed for each MCMC simulation ( both in individual studies and overall for the meta - analysis ) .", "label": "", "metadata": {}, "score": "72.59685"}
{"text": "After an average follow - up of 5.2 years , the relative risk of probable dementia for CE - alone versus placebo was 1.49 ( 95 percent CI , 0.83 - 2.66 ) .", "label": "", "metadata": {}, "score": "72.613625"}
{"text": "Results of a meta - analysis of three studies yielded inconclusive evidence regarding risk of venous thromboembolism ( VTE ) by estrogen dose .Another meta - analysis of six studies suggested a not statistically significant trend toward increased risk of VTE associated with third- and fourth - generation progestins .", "label": "", "metadata": {}, "score": "72.70566"}
{"text": "KQ 3 : Does the use of OCs by specific populations of women ( e.g. , those defined by age , family history of breast and ovarian cancer , BRCA1/BRCA2 mutation status , parity ) affect the relative risk of developing ovarian cancer ?", "label": "", "metadata": {}, "score": "72.749146"}
{"text": "Results at Weeks 4 , 8 , and 12 of treatment are shown in Figure 2 .Figure 2 : Mean ( SD ) change from baseline in mean daily number of hot flushes for Vivelle 0.0375 mg versus Placebo in a 12-week trial .", "label": "", "metadata": {}, "score": "72.784355"}
{"text": "Earlier age at first OC use was associated with a nonsignificant trend toward a greater reduction in ovarian cancer incidence , but most studies did not adjust for potential confounding due to duration of use .", "label": "", "metadata": {}, "score": "72.81256"}
{"text": "Rodriguez C , Patel AV , Calle EE , Jacob EJ , Thun MJ .Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women .", "label": "", "metadata": {}, "score": "72.84093"}
{"text": "We used two main types of comparisons .First , we performed a \" counterfactual analysis , \" based on current population use , to estimate the population difference in outcomes if OCs were not associated with any of the harms or benefits considered in the review .", "label": "", "metadata": {}, "score": "72.85534"}
{"text": "As a result , we found considerable evidence that overall rates were confounded by race and ethnicity .We were unable to adequately control for this confounding in calculating overall rates .", "label": "", "metadata": {}, "score": "72.91127"}
{"text": "KQ 6 : Based on the comprehensive literature review , what are the benefits and harms from the use of OCs to reduce the incidence of ovarian cancer for specific populations ?", "label": "", "metadata": {}, "score": "72.93436"}
{"text": "Participants were grouped by diabetes status at baseline , and the \u03c7 2 test and t test were used to evaluate differences in proportions and means for the baseline characteristics between diabetic and nondiabetic participants .", "label": "", "metadata": {}, "score": "73.00307"}
{"text": "Diabetes status .Individuals were classified as having diabetes if they reported taking antidiabetes medications in the last 48 h on the baseline questionnaire .Cancer incidence and mortality assessment .", "label": "", "metadata": {}, "score": "73.05454"}
{"text": "Journal of the National Cancer Institute .\" DCIS patients who get invasive breast cancer have higher mortality , study finds . \"ScienceDaily .Their findings reveal key host cell and ... read more .", "label": "", "metadata": {}, "score": "73.096085"}
{"text": "Journal of the National Cancer Institute , 2011 ; DOI : 10.1093/jnci / djr027 .Journal of the National Cancer Institute .\" DCIS patients who get invasive breast cancer have higher mortality , study finds . \"", "label": "", "metadata": {}, "score": "73.24361"}
{"text": "The USPSTF found good evidence that [ the service ] improves important health outcomes and concludes that benefits substantially outweigh harms .B. .The USPSTF recommends that clinicians provide [ the service ] to eligible patients .", "label": "", "metadata": {}, "score": "73.2775"}
{"text": "The USPSTF found good evidence that [ the service ] improves important health outcomes and concludes that benefits substantially outweigh harms .B. .The USPSTF recommends that clinicians provide [ the service ] to eligible patients .", "label": "", "metadata": {}, "score": "73.2775"}
{"text": "Visual inspection of the funnel plot for lymph node metastasis , ( Figure 6 ) , showed that two studies , [ 8 , 64 ] , were highly influential in the result of Egger 's asymmetry test .", "label": "", "metadata": {}, "score": "73.33955"}
{"text": "The association between health care coverage and the use of cancer screening tests .Results from the 1992 National Health Interview Survey .Med Care .", "label": "", "metadata": {}, "score": "73.33976"}
{"text": "PubMed View Article .Chikman B , Lavy R , Tolstov G , Habler L , Kapiev A , Halevy A , Sandbank J : Significance of Fascin expression in high grade breast cancer .", "label": "", "metadata": {}, "score": "73.42671"}
{"text": "PubMed View Article .Hashimoto Y , Skacel M , Adams JC : Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas : an immunohistochemical study of clinically annotated tumors .", "label": "", "metadata": {}, "score": "73.42884"}
{"text": "PubMed View Article . :The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups .Nature 2012 , 486 : 346 - 352 .", "label": "", "metadata": {}, "score": "73.486374"}
{"text": "5 A pooled quantitative estimate of this period would allow clinicians to juxtapose a screening test 's time lag to benefit to a patient 's life expectancy , to determine whether an individual patient is likely to benefit from screening .", "label": "", "metadata": {}, "score": "73.54104"}
{"text": "Pooled analysis of all carcinomas within our dataset provides strong evidence that fascin-1 may have potential as a novel biomarker for early identification of aggressive and metastatic tumors .", "label": "", "metadata": {}, "score": "73.56014"}
{"text": "Using a net - benefits approach , we assessed the impact of different \" willingness - to - pay \" thresholds in terms of harms incurred versus benefits gained for both incidence and mortality , along with the relative contribution of specific clinical harms and benefits .", "label": "", "metadata": {}, "score": "73.626915"}
{"text": "2004;11(6 pt 1):589 - 600 .Abramson BL .Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease .Recommendation statement from the Canadian Task Force on Preventive Health Care [ published correction appears in CMAJ 2004;170:1650].", "label": "", "metadata": {}, "score": "73.653595"}
{"text": "Am J Pathol 2010 , 176 : 939 - 951 .PubMed View Article .BMC Cancer 2006 , 6 : 296 .PubMed View Article .", "label": "", "metadata": {}, "score": "73.66525"}
{"text": "Numbers of the Asian / Pacific Islander and American Indian / Alaskan Native groups were insufficient to examine separately when further divided into socioeconomic groups .", "label": "", "metadata": {}, "score": "73.67604"}
{"text": "Study only reports outcomes related to assisted reproductive technologies or abortion .Timing .Studies of any duration .None .Setting .All settings .", "label": "", "metadata": {}, "score": "73.74063"}
{"text": "Key Findings and Strength of Evidence .The direction and size of the effect of OC use on the individual outcomes we assessed was consistent with previous systematic reviews .", "label": "", "metadata": {}, "score": "73.80154"}
{"text": "Women and their physicians should discuss the balance of risks and benefits before deciding to initiate or continue hormone therapy for menopausal symptoms .The populations of women using hormone therapy for symptom relief may differ from those who would use hormone therapy for prevention of chronic disease ( e.g. , age differences ) .", "label": "", "metadata": {}, "score": "73.99913"}
{"text": "Finally , we assessed the impact of uncertainty in the estimates of OC effects by using a method analogous to cost - effectiveness analysis .Instead of estimating a cost - effectiveness ratio , we estimated harm - to - benefit ratios , where total harms were considered \" costs , \" and total benefits \" effectiveness .", "label": "", "metadata": {}, "score": "74.002396"}
{"text": "PubMed View Article .Kayani B , Zacharakis E , Ahmed K , Hanna GB : Lymph node metastases and prognosis in oesophageal carcinoma -- a systematic review .", "label": "", "metadata": {}, "score": "74.06149"}
{"text": "PubMed View Article .Li X , Zheng H , Hara T , Takahashi H , Masuda S , Wang Z , Yang X , Guan Y , Takano Y : Aberrant expression of cortactin and fascin are effective markers for pathogenesis , invasion , metastasis and prognosis of gastric carcinomas .", "label": "", "metadata": {}, "score": "74.076675"}
{"text": "Zhonghua Yi XueZa Zhi 2007 , 87 : 2494 - 2498 .PubMed .Begley CG , Ellis LM : Drug development : raise standards for preclinical cancer research .", "label": "", "metadata": {}, "score": "74.09656"}
{"text": "Because data on cancer incidence and mortality were available in the same population , we further calculated the attributable fractions ( AFs ) to isolate effects of diabetes on cancer incidence from its effects on cancer case fatality and death from all causes .", "label": "", "metadata": {}, "score": "74.13776"}
{"text": "Study design .Controlled studies ( randomized trials , cohort studies , case - control studies ) , pooled patient - level meta - analyses , or systematic reviews and study - level meta - analyses b .", "label": "", "metadata": {}, "score": "74.14994"}
{"text": "PubMed View Article .Blot WJ : Esophageal cancer trends and risk factors .Semin Oncol 1994 , 21 : 403 - 410 .PubMed .", "label": "", "metadata": {}, "score": "74.26707"}
{"text": "Estrogen and progestin did not increase the risk for endometrial cancer in HERS 5 or WHI .Data on the association between the use of hormone therapy and the risk for ovarian cancer are inconsistent .", "label": "", "metadata": {}, "score": "74.37072"}
{"text": "\" No randomized controlled trials were identified for inclusion in this review ; thus , criteria specific to randomized studies ( e.g. , methods of randomization and allocation concealment ) were not considered .", "label": "", "metadata": {}, "score": "74.558105"}
{"text": "An increase in biliary tract surgery during 6.8 years of follow - up was reported among women taking estrogen plus progestin compared with those taking placebo in HERS 9 , 26 ; the WHI has not reported on outcomes for biliary tract disease among women taking hormone therapy .", "label": "", "metadata": {}, "score": "74.572105"}
{"text": "Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease .Ann Intern Med .Miller J , Chan BK , Nelson HD .Postmenopausal estrogen replacement and risk for venous thromboembolism : a systematic review and meta - analysis for the U.S. Preventive Services Task Force [ published correction appears in Ann Intern Med 2003;138:360].", "label": "", "metadata": {}, "score": "74.59282"}
{"text": "Clinical Considerations .The balance of benefits and harms for a woman will be influenced by her personal preferences , risk for specific chronic diseases , and the presence of menopausal symptoms .", "label": "", "metadata": {}, "score": "74.72858"}
{"text": "These studies also indicate differences in cancer survival and in stage at diagnosis of cancer in relation to socioeconomic factors .Because individual - level data on SES are not always available for large cancer datasets , such as those collected by the Texas Cancer Registry ( TCR ) , large population - based studies are often not available to directly investigate this relationship .", "label": "", "metadata": {}, "score": "74.91884"}
{"text": "Ever use of OCs was consistently associated with a decreased risk of developing invasive ovarian cancer ( odds ratio [ OR ] , 0.73 ; 95 % CI , 0.66 to 0.81 ) .", "label": "", "metadata": {}, "score": "75.02796"}
{"text": "Chinese J Clin Oncol 2009 , 36 : 926 - 929 .Choi PJ , Yang DK , Son CH , Lee KE , Lee JI , Roh MS : Fascin immunoreactivity for preoperatively predicting lymph node metastases in peripheral adenocarcinoma of the lung 3 cm or less in diameter .", "label": "", "metadata": {}, "score": "75.18188"}
{"text": "Minnesota Colon Cancer Control Study .N Engl J Med 1993 ; 328 : 1365 -71 .Higgins JPT , Deeks JJ , Altman DG , eds .", "label": "", "metadata": {}, "score": "75.277145"}
{"text": "Table 4 : Relative and Absolute Risk Seen in the Estrogen Plus Progestin Substudy of WHI at an Average of 5.6 Years a , b .", "label": "", "metadata": {}, "score": "75.36963"}
{"text": "Conversely , 28 % of Hispanics live in Low SES counties compared with 4 % of blacks and 5 % of white non - Hispanics .", "label": "", "metadata": {}, "score": "75.3813"}
{"text": "The Heart and Estrogen / progestin Replacement Study .Ann Intern Med .American College of Obstetricians and Gynecologists .Women 's Health Care Physicians .", "label": "", "metadata": {}, "score": "75.38759"}
{"text": "Furthermore , a number of previous studies have shown that fascin-1 is expressed in many cancer types including cancers of the biliary duct , bladder , brain , breast , colorectal , kidney , liver , ovary , pancreas and so forth [ 6 ] .", "label": "", "metadata": {}, "score": "75.40293"}
{"text": "[ PubMed ID : 16118381 ] .Miller ER 3rd , Pastor - Barriuso R , Dalal D , et al .Meta - analysis : high - dosage vitamin E supplementation may increase all - cause mortality .", "label": "", "metadata": {}, "score": "75.419525"}
{"text": "Table G. Strength of evidence domains for the effect of OC use on venous thromboembolism .Effect .Consistent .Direct .Precise .High Low dose : 3.39 ( 2.32 to 4.96 ) High dose : 3.06 ( 1.32 to 7.10 ) .", "label": "", "metadata": {}, "score": "75.43414"}
{"text": "Chan C , Jankova L , Fung CL , Clarke C , Robertson G , Chapuis PH , Bokey L , Lin BP , Dent OF , Clarke S : Fascin expression predicts survival after potentially curative resection of node - positive colon cancer .", "label": "", "metadata": {}, "score": "75.465294"}
{"text": "For breast cancer screening ( using mammography ) , we examined population based , randomized controlled trials conducted in Sweden 22 ( Goteborg , 23 Malmo I , 24 Ostergotland , 16 Stockholm 25 ) and the US ( New York ) ( table 1 ) .", "label": "", "metadata": {}, "score": "75.47229"}
{"text": "First , the diagnosis of diabetes and fasting glucose data were not available in the study , and diabetes status was not updated during follow - up .", "label": "", "metadata": {}, "score": "75.49284"}
{"text": "Lacey JV Jr , Mink PJ , Lubin JH , Sherman ME , Troisi R , Hartge P , et al .Menopausal hormone replacement therapy and risk of ovarian cancer [ published correction appears in JAMA 2002;288:2544].", "label": "", "metadata": {}, "score": "75.539246"}
{"text": "The overall strength of evidence is reduced because of the risk of bias in observational studies .Myocardial Infarction .Table I shows the strength of evidence for the effect of OC use on myocardial infarction ( MI ) .", "label": "", "metadata": {}, "score": "75.54631"}
{"text": "Humphrey L , Takano L , Chan BK .Postmenopausal hormone replacement therapy and cardiovascular disease .Systematic evidence review no . 10 .Agency for Healthcare Research and Quality , 2002 .", "label": "", "metadata": {}, "score": "75.64008"}
{"text": "Table I. Strength of evidence domains for the effect of OC use on myocardial infarction .Effect .Comparison .Number of Studies ( Women and/or Person - Years ) .", "label": "", "metadata": {}, "score": "75.66834"}
{"text": "J Korean Soc Coloproctol 2009 , 25 : 393 - 400 .View Article .Pang Q , Zhang X , Zhang J , Li Y , Wu W , Wang H , Cui A , Zhang Y : Correlative studies on expression of CXCR4 , CXCR12 , Fascin and E - cadherin in colorectal carcinoma with lymphatic metastasis .", "label": "", "metadata": {}, "score": "75.68474"}
{"text": "Of these , 5 were case - control studies representing 3,552 cases and 4,713 controls , and 1 was a cohort study representing 103,552 participants .", "label": "", "metadata": {}, "score": "75.71763"}
{"text": "CONCLUSIONS In this prospective cohort , diabetes appears to exert a greater influence downstream on the risk of mortality in people with cancer than on upstream risk of incident cancer .", "label": "", "metadata": {}, "score": "75.79025"}
{"text": "There is substantial remaining uncertainty about the joint effects of age at first OC use and duration of use on optimizing the net noncontraceptive benefits of OCs .", "label": "", "metadata": {}, "score": "75.81937"}
{"text": "By race and ethnicity , Hispanics had the highest uninsured rates with 41 % , followed by blacks with 26 % .An important limitation of this study is the potential for ecologic fallacy ( ie , interpreting the area or aggregate county socioeconomic effects as individual - level effects ) .", "label": "", "metadata": {}, "score": "75.842415"}
{"text": "Many immunohistochemical studies of fascin-1 protein in carcinomas have been published .The majority of these immunohistochemical studies have correlated fascin-1 protein in the primary tumor with poor prognosis ; however , it is not yet clear if fascin-1 has independent value as a biomarker as the individual studies are not always consistent .", "label": "", "metadata": {}, "score": "75.859146"}
{"text": "Tuberc Respir Dis 2008 , 65 : 105 - 109 .View Article .Jung EJ , Lee JH , Min BW , Kim YS , Choi JS : Clinicopathologic significance of fascin , extracellular matrix metalloproteinase inducer , and ezrin expressions in colorectal adenocarcinoma .", "label": "", "metadata": {}, "score": "75.90766"}
{"text": "Only one study [ 24 ] involved a prospectively assembled cohort while the remainder studied retrospectively assembled cohorts .The median sample size of the studies was 128.5 ( range 46 to 509 ) cases , but no studies provided a sample size or power calculation .", "label": "", "metadata": {}, "score": "75.9171"}
{"text": "Venous Thromboembolism .Table G shows the strength of evidence for the effect of OC use on venous thromboembolic events .Based on a meta - analysis of 14 studies ( 6 good quality , 6 fair quality , 2 poor quality ) , current users of OCs have a three - fold increased risk of venous thromboembolism ( OR , 2.97 ; 95 % CI , 2.46 to 3.59 ) .", "label": "", "metadata": {}, "score": "76.0644"}
{"text": "Insurance status and stage of cancer at diagnosis among women with breast cancer .Cancer .Brookfield KF , Cheung MC , Lucci J , Fleming LE , Koniaris LG .", "label": "", "metadata": {}, "score": "76.12584"}
{"text": "The B-17 trial compared lumpectomy alone to lumpectomy plus radiation therapy in women with DCIS .The B-24 trial compared lumpectomy plus radiation in combination with either tamoxifen or placebo .", "label": "", "metadata": {}, "score": "76.2413"}
{"text": "Summary of Recommendations .The USPSTF recommends against routine use of combined estrogen and progestin for the prevention of chronic conditions in postmenopausal women .D recommendation .", "label": "", "metadata": {}, "score": "76.29847"}
{"text": "BMJ 2009 ; 338 : b1846 .Segnan N , Armaroli P , Bonelli L , Risio M , Sciallero S , Zappa M , et al ; SCORE Working Group .", "label": "", "metadata": {}, "score": "76.44252"}
{"text": "In these studies , the 0.0375 and 0.05 mg doses did not differ from placebo at Week 4 , therefore , a third 12-week placebocontrolled study in 255 subjects was performed with Vivelle to establish the efficacy of the lowest dose of 0.0375 mg .", "label": "", "metadata": {}, "score": "76.48724"}
{"text": "Surveillance for disparities in maternal health - related behaviors -- selected states , Pregnancy Risk Assessment Monitoring System ( PRAMS ) , 2000 - 2001 .", "label": "", "metadata": {}, "score": "76.50232"}
{"text": "Grady D , Rubin SM , Petitti DB , Fox CS , Black D , Ettinger B , et al .Hormone therapy to prevent disease and prolong life in postmenopausal women .", "label": "", "metadata": {}, "score": "76.51449"}
{"text": "PubMed View Article .Riley RD , Sauerbrei W , Altman DG : Prognostic markers in cancer : the evolution of evidence from single studies to meta - analysis , and beyond .", "label": "", "metadata": {}, "score": "76.58742"}
{"text": "Evidence - based guidelines for cardiovascular disease prevention in women .Circulation .North American Menopause Society .Recommendations for estrogen and progestogen use in peri- and postmenopausal women : October 2004 position statement of The North American Menopause Society .", "label": "", "metadata": {}, "score": "76.64115"}
{"text": "When study designs and outcomes reported were similar and the population in the study was broad ( e.g. , not factor V Leiden carriers ) , we estimated pooled odds ratios with 95 % confidence intervals ( 95 % confidence intervals [ CIs ] ) using a random - effects model .", "label": "", "metadata": {}, "score": "76.75714"}
{"text": "The overall strength of evidence was moderate to low .There was general consistency across studies in both the direction and magnitude of the effect of OCs on disease incidence , but all of the empiric evidence was derived from observational studies , raising the possibility of unmeasured confounding .", "label": "", "metadata": {}, "score": "77.03992"}
{"text": "For the total population , 14 % reside in High SES counties , 73 % in Intermediate SES counties , and 13 % in Low SES counties .", "label": "", "metadata": {}, "score": "77.12518"}
{"text": "The absolute risk of probable dementia for CE plus MPA versus placebo was 45 versus 22 per 10,000 women - years .Probable dementia as defined in this study included AD , VaD and mixed type ( having features of both AD and VaD ) .", "label": "", "metadata": {}, "score": "77.133766"}
{"text": "For time - to - disease progression analysis , a positive hazard ratio ( HR ) implies an increased risk of disease progression .When a measure of effect ( for example , hazard ratio ) was adjusted for covariates , it was also extracted along with details of the corresponding covariates .", "label": "", "metadata": {}, "score": "77.13808"}
{"text": "Diabetes was defined by self - reported use of diabetes medications at baseline .Cancer incidence was ascertained using county and state cancer registries .Mortality data were obtained from death certificates .", "label": "", "metadata": {}, "score": "77.14043"}
{"text": "Colditz GA , Hankinson SE , Hunter DJ , Willett WC , Manson JE , Stampfer MJ , et al .The use of estrogens and progestins and the risk of breast cancer in postmenopausal women .", "label": "", "metadata": {}, "score": "77.17417"}
{"text": "Subgroup analysis of studies that presented multivariable analysis results showed that fascin-1 protein was associated with a 44 % increased risk of mortality .Ideally , meta - analysis would be based on the data of individual patients to allow for standardized control for confounding across all studies [ 82 ] .", "label": "", "metadata": {}, "score": "77.20214"}
{"text": "OBJECTIVE To quantify the association of treated diabetes with cancer incidence and cancer mortality as well as cancer case fatality and all - cause mortality in adults who subsequently develop cancer and to calculate attributable fractions due to diabetes on various cancer outcomes .", "label": "", "metadata": {}, "score": "77.25392"}
{"text": "PubMed View Article . del Rosario A , Goncharuk VN , Tran TA , Sheehan CE , Ross JS : Fascin immunoreactivity correlates with tumor grade in non - small cell lung cancer ( NSCLC ) .", "label": "", "metadata": {}, "score": "77.35217"}
{"text": "J Natl Cancer Inst 2011 ; 103 : 1310 -22 .Atkin WS , Edwards R , Kralj - Hans I , Wooldrage K , Hart AR , Northover JM , et al ; UK Flexible Sigmoidoscopy Trial Investigators .", "label": "", "metadata": {}, "score": "77.37189"}
{"text": "For example , two studies [ 58 , 66 ] categorized 0 to 8 as low expression and 9 to 12 as high expression .These differences could possibly discard potentially important quantitative information and reduce statistical power to detect real associations [ 73 ] .", "label": "", "metadata": {}, "score": "77.40368"}
{"text": "View Article .Rodriguez - Pinilla SM : Fascin and caveolin expression are associated with the basal - like subtype of invasive breast carcinoma .Virchows Archiv 2005 , 447 : 244 - 245 .", "label": "", "metadata": {}, "score": "77.42868"}
{"text": "34 Using 200 000 MCMC simulations , we obtained meta - analyzed point estimates , standard errors , and confidence intervals for annual rates of cause specific mortality in controls and screened patients .", "label": "", "metadata": {}, "score": "77.4855"}
{"text": "C. .The USPSTF makes no recommendation for or against routine provision of [ the service].The USPSTF found at least fair evidence that [ the service ] can improve health outcomes but concludes that the balance of benefits and harms is too close to justify a general recommendation . D. .", "label": "", "metadata": {}, "score": "77.51372"}
{"text": "C. .The USPSTF makes no recommendation for or against routine provision of [ the service].The USPSTF found at least fair evidence that [ the service ] can improve health outcomes but concludes that the balance of benefits and harms is too close to justify a general recommendation . D. .", "label": "", "metadata": {}, "score": "77.51372"}
{"text": "Diabetes - related cardiovascular disease no doubt plays a major role here .It is possible that cancer 's adverse effects on thrombosis and oxygenation , as well as the cardiovascular risks imposed by cancer surgery , will create adverse biological interactions ( 21 ) .", "label": "", "metadata": {}, "score": "77.515045"}
{"text": "Reports are also received from outpatient clinics , freestanding pathology laboratories , and other state central cancer registries when a Texas resident is diagnosed or treated at a facility outside of Texas .", "label": "", "metadata": {}, "score": "77.66461"}
{"text": "Figure B. Increase or decrease in age - specific incidence of cancers in ever OC users versus never users .Figure C. Increase in age - specific incidence of vascular events in current OC users versus noncurrent users .", "label": "", "metadata": {}, "score": "77.6799"}
{"text": "Cholecystitis .Results from the Nurses ' Health Study , a good - quality cohort study , reported an increased risk for cholecystitis among current hormone therapy users and long - term users ( longer than five years ) compared with nonusers .", "label": "", "metadata": {}, "score": "77.685974"}
{"text": "Health , United States , 1998 .Hyattsville , Maryland : National Center for Health Statistics .Singh GK , Hankey BF , Edwards BK .", "label": "", "metadata": {}, "score": "77.75902"}
{"text": "There was some evidence that risk of thromboembolism decreased with an increased duration of use , but there were not enough studies for a meta - analysis .", "label": "", "metadata": {}, "score": "77.818825"}
{"text": "PubMed View Article .Lecomte N , Njardarson JT , Nagorny P , Yang G , Downey R , Ouerfelli O , Moore MA , Danishefsky SJ : Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin .", "label": "", "metadata": {}, "score": "77.84639"}
{"text": "Conclusions .Our meta - analysis study demonstrates that fascin-1 is associated with increased risk of mortality in breast , colorectal and esophageal carcinomas and with increased risk of metastasis in colorectal and gastric carcinomas .", "label": "", "metadata": {}, "score": "77.86062"}
{"text": "BENEFITS OF HORMONE THERAPY .Osteoporosis and Fractures .Good evidence from observational studies and randomized clinical trials demonstrates that estrogen therapy increases bone density and reduces the risk for fractures .", "label": "", "metadata": {}, "score": "78.11394"}
{"text": "PubMed View Article .Parkin DM , Bray F , Ferlay J , Pisani P : Global cancer statistics , 2002 .CA Cancer J Clin 2005 , 55 : 74 - 108 .", "label": "", "metadata": {}, "score": "78.25564"}
{"text": "PubMed View Article .Duchateau L , Collette L , Sylvester R , Pignon JP : Estimating number of events from the Kaplan - Meier curve for incorporation in a literature - based meta - analysis : what you do n't see you ca n't get ! Biometrics 2000 , 56 : 886 - 892 .", "label": "", "metadata": {}, "score": "78.26019"}
{"text": "Participants in each study were randomized to receive an invitation to screen versus usual care .Screening regimens varied by individual trial ( range 2 - 8 rounds of mammography ) .", "label": "", "metadata": {}, "score": "78.28597"}
{"text": "Interventions .OC use ( includes OC use for varying time periods and OC use with different formulations ) .Comparators .No use of combination or progestin - only OCs , including either no contraceptive method at all or contraceptive methods other than combination or progestin - only OCs ( e.g. , natural family planning , barrier methods , sterilization , intrauterine devices , injectable or implantable hormonal contraception ) .", "label": "", "metadata": {}, "score": "78.336266"}
{"text": "These data will assist rational decision making for focusing investigations of fascin-1 as a biomarker or therapeutic target onto the most relevant carcinomas .Keywords .", "label": "", "metadata": {}, "score": "78.40611"}
{"text": "Miller J , Chan BK , Nelson H. Hormone replacement therapy and risk of venous thromboembolism .Systematic evidence review no .11 .Agency for Healthcare Research and Quality , 2002 .", "label": "", "metadata": {}, "score": "78.40642"}
{"text": "In normal epithelia , fascin-1 is usually absent or present at low levels , yet its expression is increased in colorectal adenomas , esophageal dysplasia and in many carcinomas [ 2 - 8 ] .", "label": "", "metadata": {}, "score": "78.419075"}
{"text": "Results from the four Swedish trials were combined into one study , stratified by age .22 Because of our focus on older patients , we relied on age stratified data ( 55 - 64 years ; 65 - 74 years ) provided by this paper .", "label": "", "metadata": {}, "score": "78.45874"}
{"text": "Secondly , although avoiding death from cancer is a critical benefit , avoiding symptoms related to cancer is also important .Since cancer symptoms will usually precede cancer death , the time lag to avoiding cancer symptoms will be shorter than the time lag to avoiding cancer death .", "label": "", "metadata": {}, "score": "78.577614"}
{"text": "KQ 7 : Based on the systematic review and decision model , what research gaps need to be filled to better understand whether OCs are effective for the primary prevention of ovarian cancer ?", "label": "", "metadata": {}, "score": "78.59505"}
{"text": "Probable dementia as defined in this study included Alzheimer 's disease ( AD ) , vascular dementia ( VaD ) and mixed type ( having features of both AD and VaD ) .", "label": "", "metadata": {}, "score": "78.60721"}
{"text": "Sellers TA , Mink PJ , Cerhan JR , Zheng W , Anderson KE , Kushi LH , et al .The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer .", "label": "", "metadata": {}, "score": "78.65767"}
{"text": "The dashed vertical line is the overall pooled estimate across all included studies and carcinomas .Gastric carcinoma .Three studies [ 55 - 57 ] examined the association of fascin-1 positivity of carcinomas with mortality , with a total of 750 gastric carcinoma cases .", "label": "", "metadata": {}, "score": "79.02574"}
{"text": "PubMed View Article .Br J Cancer 2007 , 96 : 1118 - 1126 .PubMed View Article .Roh MS , Um SJ , Choi Y , Kim KN , Pil JC , Lee SK , Son C , Yang D : Prognostic significance of fascin expression in stage I non - small cell lung cancer .", "label": "", "metadata": {}, "score": "79.0814"}
{"text": "Am J Pathol 1997 , 150 : 543 - 562 .PubMed .Yoder BJ , Tso E , Skacel M , Pettay J , Tarr S , Budd T , Tubbs RR , Adams JC , Hicks DG : The expression of fascin , an actin - bundling motility protein , correlates with hormone receptor - negative breast cancer and a more aggressive clinical course .", "label": "", "metadata": {}, "score": "79.17735"}
{"text": "Machesky LM , Li A : Fascin : invasive filopodia promoting metastasis .Commun Integr Biol 2010 , 3 : 263 - 270 .PubMed View Article .", "label": "", "metadata": {}, "score": "79.23186"}
{"text": "We were able to perform a meta - analysis of three case - control studies of estrogen level , which found a significant increase in risk with increased estrogen dose ( although stroke risk with low - dose formulations was still significantly elevated compared with nonusers ) .", "label": "", "metadata": {}, "score": "79.29489"}
{"text": "Results of a meta - analysis of 29 good - quality , observational studies of endometrial cancer reported an RR of 2.3 for users of unopposed estrogen compared with nonusers .", "label": "", "metadata": {}, "score": "79.3076"}
{"text": "There were too few studies to perform a meta - analysis of duration of use or of estrogen dose .Risks were significantly higher with first - generation progestins compared with second- and third - generation formulations .", "label": "", "metadata": {}, "score": "79.35485"}
{"text": "Thus , diabetes appears to exert a greater influence downstream on the risk of mortality in people with cancer than on upstream risk of incident cancer .", "label": "", "metadata": {}, "score": "79.46504"}
{"text": "References .Diamandis EP : Cancer biomarkers : can we turn recent failures into success ?J Natl Cancer Inst 2010 , 102 : 1462 - 1467 .", "label": "", "metadata": {}, "score": "79.54126"}
{"text": "While earlier studies showed a beneficial effect of hormone therapy on cognition , these studies had marked heterogeneity and variation in assessment of outcomes .18 Because of issues of internal and external validity from these previous studies , the more recent , fair - quality WHI memory studies are more likely to represent the effects of hormone therapy use in the healthy postmenopausal population .", "label": "", "metadata": {}, "score": "79.564835"}
{"text": "Grodstein F , Colditz GA , Stampfer MJ .Postmenopausal hormone use and cholecystectomy in a large prospective study .Obstet Gynecol .Simon JA , Hunninghake DB , Agarwal SK , Lin F , Cauley JA , Ireland CC , et al .", "label": "", "metadata": {}, "score": "79.60455"}
{"text": "PubMed View Article .Kim BG , Ha KW , Park JS , Yoo JH : Immunohistochemical studies of fascin , MMP-9 overexpression , and proliferating index as prognostic factors in cases of a colon adenocarcinoma .", "label": "", "metadata": {}, "score": "79.63669"}
{"text": "At the full - text screening stage , two investigators independently reviewed the full text of each article and indicated a decision to include or exclude the article for data abstraction .", "label": "", "metadata": {}, "score": "79.71608"}
{"text": "Consistent .Direct .Imprecise .Insufficient NR .Progestin .5 ( 8,875 women ) .Medium .Consistent .Direct .Precise .High First generation : 3.37 ( 2.04 to 5.54 ) Second generation : 1.79 ( 1.16 to 2.75 )", "label": "", "metadata": {}, "score": "79.726776"}
{"text": "By David R. Risser , PhD , MPH ; Eric A. Miller , PhD ; Melanie A. Williams , PhD ; and Lewis E. Foxhall , MD .", "label": "", "metadata": {}, "score": "79.81482"}
{"text": "The USPSTF recommends against the routine use of unopposed estrogen for the prevention of chronic conditions in postmenopausal women who have had a hysterectomy .D recommendation .", "label": "", "metadata": {}, "score": "79.83978"}
{"text": "PubMed View Article .Kawase A , Yoshida J , Ishii G , Nakao M , Aokage K , Hishida T , Nishimura M , Nagai K : Differences between squamous cell carcinoma and adenocarcinoma of the lung : are adenocarcinoma and squamous cell carcinoma prognostically equal ?", "label": "", "metadata": {}, "score": "79.89224"}
{"text": "PubMed View Article .Zhao J , Zhou Y , Zhang Z , Tian F , Ma N , Liu T , Gu Z , Wang Y : Upregulated fascin1 in non - small cell lung cancer promotes the migration and invasiveness , but not proliferation .", "label": "", "metadata": {}, "score": "79.90533"}
{"text": "This conclusion is based on a meta - analysis of 15 studies .Of these , 10 were case - control studies representing 6,901 cases and 15,999 controls , and 5 were cohort studies representing 524,463 participants in 3 of the studies and 3,493,072 person - years in the other two studies .", "label": "", "metadata": {}, "score": "79.95923"}
{"text": "Participants in each study were randomized to receive an invitation to screen versus usual care .Screening regimens varied by individual study ( range 2 - 11 rounds of fecal occult blood tests ) .", "label": "", "metadata": {}, "score": "80.01436"}
{"text": "Four studies were rated good quality and four were rated fair quality .We excluded studies that used fewer than three comparisons and studies that presented categories that were not amenable to a combined analysis .", "label": "", "metadata": {}, "score": "80.06253"}
{"text": "So many comparisons were made examining secondary outcomes and subgroups that caution is needed in interpreting any of these marginally significant findings , such as vitamin E reducing CV death or aspirin increasing cancer in never - smokers .", "label": "", "metadata": {}, "score": "80.08273"}
{"text": "KQ 1 : What is the effectiveness of combined ( estrogen and progestin containing ) and progestin - only OCs for reducing the risk of ovarian cancer ?", "label": "", "metadata": {}, "score": "80.13252"}
{"text": "This was because we excluded studies that did not include older women , and we included studies that the Cochrane review rated as \" suboptimal \" but not \" likely biased \" ( Health Insurance Plan - New York , Goteborg , and Stockholm ) .", "label": "", "metadata": {}, "score": "80.26517"}
{"text": "Assessing the Applicability of Studies When Comparing Medical Interventions .Agency for Healthcare Research and Quality ; January 2011 .Methods Guide for Comparative Effectiveness Reviews .", "label": "", "metadata": {}, "score": "80.37343"}
{"text": "Evidence includes consistent results from well - designed , well - conducted studies in representative populations that directly assess effects on health outcomes .Fair : .", "label": "", "metadata": {}, "score": "80.38383"}
{"text": "Evidence includes consistent results from well - designed , well - conducted studies in representative populations that directly assess effects on health outcomes .Fair : .", "label": "", "metadata": {}, "score": "80.38383"}
{"text": "U.S. Preventive Services Task Force .Postmenopausal hormone replacement therapy to prevent chronic conditions : recommendations from the U.S. Preventative Services Task Force .Ann Intern Med .", "label": "", "metadata": {}, "score": "80.399994"}
{"text": "Thus , the diabetic individuals in our study may be later in the natural history of their diabetes than in other studies .The consequent misclassification of adults with undiagnosed and untreated diabetes as nondiabetic likely biased our results toward the null .", "label": "", "metadata": {}, "score": "80.49277"}
{"text": "Quality of studies .The methodological quality of studies which presented mortality data was judged and agreed to by three assessors ( RMM , SJL and VYT ) using the Newcastle - Ottawa scale [ 27 ] , which was developed to assess the quality of non - randomized cohort studies in meta - analysis .", "label": "", "metadata": {}, "score": "80.58739"}
{"text": "Finally , one of the strengths of this review was that all included studies used the same two antibodies for the IHC .It would be interesting to see if the hazard ratio remains the same if the outcomes from these studies are examined according to the individual antibody used .", "label": "", "metadata": {}, "score": "80.60051"}
{"text": "The USPSTF found at least fair evidence that [ the service ] is ineffective or that harms outweigh benefits .I. .The USPSTF concludes that the evidence is insufficient to recommend for or against routinely providing [ the service].", "label": "", "metadata": {}, "score": "80.712875"}
{"text": "The USPSTF found at least fair evidence that [ the service ] is ineffective or that harms outweigh benefits .I. .The USPSTF concludes that the evidence is insufficient to recommend for or against routinely providing [ the service].", "label": "", "metadata": {}, "score": "80.712875"}
{"text": "The dashed vertical line is the overall pooled estimate across all included studies and carcinomas .Time - to - disease progression was calculated from the date of surgery to the date of disease progression .", "label": "", "metadata": {}, "score": "80.7786"}
{"text": "The authors would like to acknowledge the technical assistance of George Lara , research specialist , for linking the County Attributes data from the 2000 US Census to the Texas Cancer Registry incidence and mortality datasets .", "label": "", "metadata": {}, "score": "80.920876"}
{"text": "P- values are from the results of Egger 's test to assess publication bias .Discussion .The importance of demonstrating the reproducibility of biomarker studies to validate their utility for the clinic is increasingly well recognized [ 67 ] .", "label": "", "metadata": {}, "score": "80.92378"}
{"text": "This study provided additional evidence that SES plays a role in disparities of cancer incidence and mortality rates in data specific for Texas .Consistent with previous studies , we found that the poorer counties in Texas bear a greater burden of cancer than do higher SES counties .", "label": "", "metadata": {}, "score": "80.93061"}
{"text": "Zhang H , Xu L , Xiao D , Xie J , Zeng H , Cai W , Niu Y , Yang Z , Shen Z , Li E : Fascin is a potential biomarker for early - stage oesophageal squamous cell carcinoma .", "label": "", "metadata": {}, "score": "80.99975"}
{"text": "The model was run as a microsimulation , which allowed for conditioning of probabilities based on past history .Depending on the analysis , each model run included 5,000 to 1,000,000 simulated individuals ; estimates of the outcomes of interest were based on the mean value of each model run ( or , in some cases , the weighted average of multiple model runs ) .", "label": "", "metadata": {}, "score": "81.069756"}
{"text": "Then , as proposed by Ouwens and colleagues , 34 we fit Weibull survival curves for each study 's arm ( control or intervention ) using a joint random effects model on both the shape and scale parameters .", "label": "", "metadata": {}, "score": "81.29825"}
{"text": "PubMed View Article .Takikita M , Hu N , Shou JZ , Giffen C , Wang QH , Wang C , Hewitt SM , Taylor PR : Fascin and CK4 as biomarkers for esophageal squamous cell carcinoma .", "label": "", "metadata": {}, "score": "81.34949"}
{"text": "In the subset of participants with valid responses for the food frequency questionnaire , the results were similar to the overall cohort after further adjustment for alcohol consumption ( data not shown ) .", "label": "", "metadata": {}, "score": "81.3996"}
{"text": "JAMA .Shumaker SA , Legault C , Kuller L , Rapp SR , Thal L , Lane DS , et al .Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women : Women 's Health Initiative Memory Study .", "label": "", "metadata": {}, "score": "81.40637"}
{"text": "The USPSTF grades the quality of the overall evidence for a service on a three - point scale ( good , fair , or poor ) .", "label": "", "metadata": {}, "score": "81.458664"}
{"text": "We identified duplicate publications by reviewing study name , authors , location , study population , dates and study design .For multiple study publications from the same patient cohort reporting on similar outcomes , we chose the study with the largest number of cases .", "label": "", "metadata": {}, "score": "81.601105"}
{"text": "Black men .Am J Public Health .Ben - Shlomo Y , Smith GD .Commentary : socioeconomic position should be measured accurately .BMJ .", "label": "", "metadata": {}, "score": "81.697205"}
{"text": "At baseline , written informed consent was obtained , and a short questionnaire on demographics and medical history were administered to all participants .A total of 32,894 individuals , nearly one - third of the adult population of Washington County at that time , took part in this study .", "label": "", "metadata": {}, "score": "82.00454"}
{"text": "Hashimoto Y , Skacel M , Lavery IC , Mukherjee AL , Casey G , Adams JC : Prognostic significance of fascin expression in advanced colorectal cancer : an immunohistochemical study of colorectal adenomas and adenocarcinomas .", "label": "", "metadata": {}, "score": "82.083176"}
{"text": "CLINICAL PHARMACOLOGY .Mechanism of Action .Endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics .", "label": "", "metadata": {}, "score": "82.11802"}
{"text": "NA .Direct .Imprecise .Insufficient ( not performed ) a .Key Question 2 .Effect of Specifics of OC Use on Ovarian Cancer Incidence .", "label": "", "metadata": {}, "score": "82.25128"}
{"text": "In some cases , data from a study composed of more than one article could not be combined into one abstraction .In those instances , the quality ratings for individual abstractions within a study grouping could vary based on the specific component articles ' quality of reporting , the evaluated outcomes , and the statistical and analytical methods used .", "label": "", "metadata": {}, "score": "82.25378"}
{"text": "Because of the ecologic approach , some misclassification by poverty level will occur .In this analysis , the poverty level was determined at the county level , which assumes that everyone of each race and ethnicity in a county falls into that category .", "label": "", "metadata": {}, "score": "82.26788"}
{"text": "Different semi - quantitative parameters were used to categorize and dichotomize fascin-1 staining ( see Additional file 1 for alternative categorization methods used to assess immunohistochemical staining of fascin-1 ) .", "label": "", "metadata": {}, "score": "82.28156"}
{"text": "F.L.B. has received support from the NIDDK Diabetes Research and Training Center ( P60-DK-079637 ) and from the NIDDK ( K24-DK-62222 ) .", "label": "", "metadata": {}, "score": "82.34201"}
{"text": "The dashed vertical line is the overall pooled estimate across all included studies and carcinomas .Three studies [ 11 , 52 , 61 ] examined the association of fascin-1 positivity of carcinomas with distant metastasis and one [ 54 ] examined the association of high fascin-1 with distant metastasis , with a total of 684 colorectal carcinoma cases .", "label": "", "metadata": {}, "score": "82.39047"}
{"text": "One subject had a complete detachment during the wear period .Approximately 65 percent of the transdermal systems evaluated in these studies were with MINIVELLE 0.1 mg per day ( 6.6 cm\u00b2 active surface area ) .", "label": "", "metadata": {}, "score": "82.52519"}
{"text": "PubMed View Article .Grothey A , Hashizume R , Sahin AA , McCrea PD : Fascin , an actin - bundling protein associated with cell motility , is upregulated in hormone receptor negative breast cancer .", "label": "", "metadata": {}, "score": "82.59013"}
{"text": "Without these ... read more .However , new research has enabled the identification of four genes associated with ... read more .Ductal carcinoma in situ ( DCIS ) is a precursor of ... read more .", "label": "", "metadata": {}, "score": "82.63092"}
{"text": "Alternatively , pooled analyses of individual data collected across multiple studies offers an opportunity to address some of these shortcomings of reporting , but this approach is still dependent on consistency in how data is collected .", "label": "", "metadata": {}, "score": "82.670494"}
{"text": "16 , 17 Five of six studies that examined the effects of hormone therapy over time reported that the risk was highest within the first year of use ( RR , 3.49 ; 95 percent CI , 2.33 to 5.59 ) .", "label": "", "metadata": {}, "score": "82.67682"}
{"text": "All esophageal carcinoma studies included in our meta - analysis were carried out in Asia .Esophageal carcinoma shows marked geographic variation with exceptionally high rates in Asia [ 70 ] .", "label": "", "metadata": {}, "score": "82.677475"}
{"text": "Conclusions and perspectives .The findings of this systematic review and meta - analysis by Tan et al . are clinically relevant and important in the field of cancer biomarkers .", "label": "", "metadata": {}, "score": "82.76146"}
{"text": "The U.S. Preventive Services Task Force recommendations are independent of the U.S. government .They do not represent the views of the Agency for Healthcare Research and Quality , the U.S. Department of Health and Human Services , or the U.S. Public Health Service .", "label": "", "metadata": {}, "score": "82.795074"}
{"text": "Washington , DC : US Census Bureau ; 2007 .Krieger N , Williams DR , Moss NE .Measuring social class in US public health research : concepts , methodologies , and guidelines .", "label": "", "metadata": {}, "score": "82.84961"}
{"text": "Methods .Literature Search Strategy .We restricted the search to articles published subsequent to January 1990 to increase the likelihood that the types of OCs used by the women in the studies we retrieved were similar to those currently available , maximizing the generalizability and clinical relevance of the results .", "label": "", "metadata": {}, "score": "82.8592"}
{"text": "Borenstein M , Hedges L , Higgins J , et al .Comprehensive Meta - Analysis Version 2.0 .Biostat : Englewood , NJ ; 2005 .", "label": "", "metadata": {}, "score": "82.96083"}
{"text": "Wathen CN , Feig DS , Feightner JW , Abramson BL , Cheung AM .Hormone replacement therapy for the primary prevention of chronic diseases : recommendation statement from the Canadian Task Force on Preventive Health Care .", "label": "", "metadata": {}, "score": "83.19795"}
{"text": "We followed the Messori procedure , 28 scanning the survival curves and analyzing the scanned images to determine quantitative estimates of the annual rate of cause specific mortality .", "label": "", "metadata": {}, "score": "83.208786"}
{"text": "Older data ( with publication dates beginning January 1990 ) were used to conduct sensitivity analyses , allowing us to compare the results from the January 2000 to June 2012 analyses with those from a longer date range ( January 1990 to June 2012 ) .", "label": "", "metadata": {}, "score": "83.21399"}
{"text": "c Small nonrandomized studies less than 100 subjects were excluded because confidence intervals for outcomes of interest are generally quite wide if appropriate adjustment for confounding is performed , and variability in reporting of potential confounders makes meta - analysis problematic .", "label": "", "metadata": {}, "score": "83.267105"}
{"text": "PubMed View Article .Pinkus GS , Pinkus JL , Langhoff E , Matsumura F , Yamashiro S , Mosialos G , Said JW : Fascin , a sensitive new marker for Reed - Sternberg cells of Hodgkin 's disease .", "label": "", "metadata": {}, "score": "83.26994"}
{"text": "We were unable to obtain one paper either electronically or after contacting the authors [ 49 ] .Overall , 26 papers published between 2003 and 2011 were included in our meta - analysis ( Figure 1 ) .", "label": "", "metadata": {}, "score": "83.348625"}
{"text": "[ PubMed ID : 15537682 ] .Huang HY , Appel LJ .Supplementation of diets with alpha - tocopherol reduces serum concentrations of gamma- and delta - tocopherol in humans .", "label": "", "metadata": {}, "score": "83.485"}
{"text": "Medium .Consistent .Direct .Precise .High First generation : 4.06 ( 2.66 to 6.19 ) Second generation : 3.28 ( 2.49 to 4.31 )", "label": "", "metadata": {}, "score": "83.67676"}
{"text": "Immunohistochemistry is a pathologist - based scoring system that is the most commonly used and reliable technique in diagnostic histopathology [ 72 ] .In addition , nearly all included studies used the same two antibodies to fascin-1 , enabling comparability of prognostic effects in our meta - analysis .", "label": "", "metadata": {}, "score": "83.71854"}
{"text": "Baseline characteristics are shown in Table 1 by diabetes status .Of 18,280 participants , 599 ( 3.3 % ) had been treated for diabetes , including 354 taking oral medication , 197 receiving insulin , and 48 taking unspecified diabetes medications .", "label": "", "metadata": {}, "score": "83.72477"}
{"text": "The diamonds are pooled estimates and their 95 % confidence intervals , based on random or fixed effects meta - analysis models .The dashed vertical line is the overall pooled estimate across all included studies and carcinomas .", "label": "", "metadata": {}, "score": "83.821236"}
{"text": "7 A meta - analysis of 22 trials of estrogen reported an overall 27 percent reduction in nonvertebral fractures ( relative risk [ RR ] , 0.73 ; 95 percent CI , 0.56 to 0.94 ) , although the quality of individual studies varied .", "label": "", "metadata": {}, "score": "83.93918"}
{"text": "These domains were considered qualitatively , and a summary rating of \" high , \" \" moderate , \" or \" low \" for strength of evidence was assigned by two reviewers .", "label": "", "metadata": {}, "score": "84.11768"}
{"text": "We excluded studies investigating tissue mRNA because the extracted mRNAs derive from a mixture of cells including myofibroblasts , endothelial cells and dendritic cells that express fascin-1 constitutively [ 18 ] .", "label": "", "metadata": {}, "score": "84.13493"}
{"text": "PubMed View Article .Hsu KF , Lin CK , Yu CP , Tzao C , Lee SC , Lee YY , Tsai WC , Jin JS : Cortactin , fascin , and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma .", "label": "", "metadata": {}, "score": "84.16064"}
{"text": "Exploratory study with inadequate sample size .Publications .English - language only .Peer - reviewed articles .Outcome reporting falls within the following publication ranges : .", "label": "", "metadata": {}, "score": "84.27672"}
{"text": "WHI Estrogen - Alone Substudy .The WHI estrogen - alone substudy was stopped early because an increased risk of stroke was observed , and it was deemed that no further information would be obtained regarding the risks and benefits of estrogen - alone in predetermined primary endpoints .", "label": "", "metadata": {}, "score": "84.32364"}
{"text": "Some studies were excluded on the basis of the title or abstract ; for all others , full papers were obtained and reviewed by two independent assessors ( VYT , RMM ) , with each assessor blind to the decision of the other .", "label": "", "metadata": {}, "score": "84.36035"}
{"text": "Acknowledgments .H.-C.Y. has received support from the National Institute of Diabetes and Digestive and Kidney Diseases ( NIDDK ) Diabetes Research and Training Center ( P60-DK-079637 ) .", "label": "", "metadata": {}, "score": "84.47878"}
{"text": "USPSTF Recommendations and Ratings .The USPSTF grades its recommendations according to one of five classifications ( A , B , C , D , or I ) reflecting the strength of evidence and magnitude of net benefit ( benefits minus harms ) . A. .", "label": "", "metadata": {}, "score": "84.4962"}
{"text": "USPSTF Recommendations and Ratings .The USPSTF grades its recommendations according to one of five classifications ( A , B , C , D , or I ) reflecting the strength of evidence and magnitude of net benefit ( benefits minus harms ) . A. .", "label": "", "metadata": {}, "score": "84.4962"}
{"text": "Results .Identification and selection of included studies .The literature search retrieved a total of 3,098 studies , including 2,062 from MEDLINE , 541 from Embase , 392 from Web of Science and 103 from PubMed .", "label": "", "metadata": {}, "score": "84.51688"}
{"text": "PubMed View Article .Zhang Y , Tong X : Expression of the actin - binding proteins indicates that cofilin and fascin are related to breast tumour size .", "label": "", "metadata": {}, "score": "84.55374"}
{"text": "Authors ' Affiliations .Department of Laboratory Medicine and Pathobiology , University of Toronto .Department of Clinical Biochemistry , University Health Network .Department of Pathology and Laboratory Medicine , Mount Sinai Hospital , Mount Sinai Hospital .", "label": "", "metadata": {}, "score": "84.555214"}
{"text": "Trials were identified as high quality by reviews from the Cochrane Collaboration and United States Preventive Services Task Force .Setting Trials undertaken in the United States , Denmark , United Kingdom , and Sweden .", "label": "", "metadata": {}, "score": "84.78453"}
{"text": "Asamura H , Goya T , Koshiishi Y , Sohara Y , Eguchi K , Mori M , Nakanishi Y , Tsuchiya R , Shimokata K , Inoue H , Nukiwa T , Miyaoka E : A Japanese Lung Cancer Registry study : prognosis of 13,010 resected lung cancers .", "label": "", "metadata": {}, "score": "84.80944"}
{"text": "Estrogen - alone increased the risk for ischemic stroke , and this excess risk was present in all subgroups of women examined .Timing of the initiation of estrogen - alone therapy relative to the start of menopause may affect the overall risk benefit profile .", "label": "", "metadata": {}, "score": "84.81862"}
{"text": "Data sources .We searched the Medline , Embase , Web of Science and PubMed bibliographic databases from their inception until April 2012 , using a combined text word and MeSH heading search strategy ( see Additional file 1 for search terms ) .", "label": "", "metadata": {}, "score": "84.987114"}
{"text": "24 One study suggested higher risk with unopposed estrogen than with estrogen and progestin therapy , 22 but data are insufficient to resolve the effects of different formulations or doses of hormone therapy on ovarian cancer risk .", "label": "", "metadata": {}, "score": "85.01245"}
{"text": "Zhonghua Zhong Liu Za Zhi 2010 , 32 : 838 - 844 .PubMed .Am J Surg Pathol 2003 , 27 : 1203 - 1215 .", "label": "", "metadata": {}, "score": "85.03277"}
{"text": "f Date ranges for acute vascular events associated with OC use were restricted to more recent years to reflect currently available formulations .g Non - English articles were excluded ( 1 ) due to the high volume of literature available in English - language publications ( including the majority of known important studies ) , and ( 2 ) due to concerns about the applicability of non - English publication studies to populations in the United States .", "label": "", "metadata": {}, "score": "85.27715"}
{"text": "The investigative team created forms for abstracting the data elements for the KQs , which were pilot tested with a sample of included articles to ensure that all relevant data elements were captured and that there was consistency and reproducibility between abstractors for accuracy .", "label": "", "metadata": {}, "score": "85.40839"}
{"text": "The outer dashed lines represent the 95 % confidence limits around the summary effect estimate , within which 95 % of studies are expected to lie in the absence of both biases and heterogeneity .", "label": "", "metadata": {}, "score": "85.54471"}
{"text": "data published in BMC Medicine [ 4 ] , fascin-1 is a novel biomarker for aggressive , metastatic carcinomas .Fascin-1 is an actin - bundling protein absent in most normal epithelia but expressed in many human carcinomas [ 5 ] .", "label": "", "metadata": {}, "score": "85.544914"}
{"text": "Additional research is needed to better understand the effect of SES on cancer incidence and mortality in Texas and the specific factors underlying SES that contribute to the disparities .", "label": "", "metadata": {}, "score": "85.702156"}
{"text": "PubMed View Article .Altman DG , Lausen B , Sauerbrei W , Schumacher M : Dangers of using \" optimal \" cutpoints in the evaluation of prognostic factors .", "label": "", "metadata": {}, "score": "85.840256"}
{"text": "We confirmed the proportionality assumption by examining Schoenfeld residuals and used the Efron method to handle ties .To reduce possible detection bias from regular medical encounters in participants with treated diabetes , for the analysis of cancer incidence , a subgroup analysis was further conducted in adults who received treatment for hypertension and/or high cholesterol at baseline .", "label": "", "metadata": {}, "score": "85.84904"}
{"text": "WJB led the statistical analysis and made critical revisions to the manuscript .IS - C did the statistical analysis and made critical revisions to the manuscript .", "label": "", "metadata": {}, "score": "85.91911"}
{"text": "a The available data were not sufficient to perform a meta - analysis ; refer to full report for details .Consistent .Direct .Precise .", "label": "", "metadata": {}, "score": "85.928"}
{"text": "Immunohistochemical ( IHC ) studies have shown that fascin-1 protein expression is correlated with poor prognosis [ 6 , 7 ] .The objective of Tan et al . was to conduct a systematic review and meta - analysis of studies that used IHC to investigate whether fascin-1 could serve as an early marker for identification of aggressive metastatic potential .", "label": "", "metadata": {}, "score": "85.964584"}
{"text": "PubMed View Article .Diamandis EP : The failure of protein cancer biomarkers to reach the clinic : Why and what can be done to address the problem ?", "label": "", "metadata": {}, "score": "86.111725"}
{"text": "\" 3 To assess quality , we used the approach to ( 1 ) classify the study design , ( 2 ) apply predefined criteria for quality and critical appraisal , and ( 3 ) arrive at a summary judgment of the study 's quality .", "label": "", "metadata": {}, "score": "86.17073"}
{"text": "19 The Minnesota study had two intervention arms ( annual and biennial screening ) , each compared with the one control arm ; we split the control group and entered the two intervention arms separately into our meta - analysis .", "label": "", "metadata": {}, "score": "86.22186"}
{"text": "In the CLUE II cohort , the fraction of events attributable to diabetes rose in a graded fashion from incident cancer , to cancer case fatality , to all - cause mortality in cancer patients .", "label": "", "metadata": {}, "score": "86.22456"}
{"text": "Immunohistochemistry is a complex metric for meta - analysis , due to the use of different scoring systems to assess the extent of fascin-1 staining in tumor specimens , yet studies of fascin-1 have the advantage that almost all publications to date have used the same two antibodies to fascin-1 .", "label": "", "metadata": {}, "score": "86.259766"}
{"text": "PubMed .Ozerhan IH , Ersoz N , Onguru O , Ozturk M , Kurt B , Cetiner S : Fascin expression in colorectal carcinomas .", "label": "", "metadata": {}, "score": "86.34326"}
{"text": "Pelosi G , Pasini F , Fraggetta F , Pastorino U , Iannucci A , Maisonneuve P , Arrigoni G , De Manzoni G , Bresaola E , Viale G : Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids .", "label": "", "metadata": {}, "score": "86.3586"}
{"text": "USPSTF Strength of Overall Evidence .The USPSTF grades the quality of the overall evidence for a service on a three - point scale ( good , fair , or poor ) .", "label": "", "metadata": {}, "score": "86.514046"}
{"text": "Dig Dis 2010 , 28 : 641 - 644 .PubMed View Article .Brell M , Ibanez J , Tortosa A : O6-Methylguanine - DNA methyltransferase protein expression by immunohistochemistry in brain and non - brain systemic tumours : systematic review and meta - analysis of correlation with methylation - specific polymerase chain reaction .", "label": "", "metadata": {}, "score": "86.57131"}
{"text": "PubMed .Rodriguez - Pinilla SM , Sarrio D , Honrado E , Hardisson D , Calero F , Benitez J , Palacios J : Prognostic significance of basal - like phenotype and fascin expression in node - negative invasive breast carcinomas .", "label": "", "metadata": {}, "score": "86.63025"}
{"text": "In : Higgins JPT , Green S , eds .Cochrane handbook for systematic reviews of interventions version 5.1.0 ( updated March 2011 ) .Nelson HD , Tyne K , Naik A , Bougatsos C , Chan B , Nygren P , et al .", "label": "", "metadata": {}, "score": "86.65781"}
{"text": "Many authors did not respond to requests for information or clarification and we also identified several studies which did not report all their data .However , funnel plot analyses were not generally indicative of any strong publication bias because visual inspection of funnel plots did not show asymmetry ( Figure 6 ) .", "label": "", "metadata": {}, "score": "86.75839"}
{"text": "PubMed View Article .Vignjevic D , Schoumacher M , Gavert N , Janssen KP , Jih G , Lae M , Louvard D , Ben - Ze'ev A , Robine S : Fascin , a novel target of beta - Catenin - TCF signaling , is expressed at the invasive front of human colon cancer .", "label": "", "metadata": {}, "score": "86.82429"}
{"text": "Fourth , we lacked optimal data to characterize adiposity : BMI was calculated based on self - reported weight and height ( which tend to underestimate true BMI ) , and we lacked data on waist circumference or percent body fat .", "label": "", "metadata": {}, "score": "87.04513"}
{"text": "PubMed View Article .Sterne JA , Egger M , Smith GD : Systematic reviews in health care : investigating and dealing with publication and other biases in meta - analysis .", "label": "", "metadata": {}, "score": "87.059204"}
{"text": "12 , 13 Overall , there is a good - quality body of evidence indicating that combined estrogen and progestin increases breast cancer risk .It is unclear whether the combination of estrogen and progestin confers a greater breast cancer risk than estrogen alone .", "label": "", "metadata": {}, "score": "87.139084"}
{"text": "Discussion .The median age of menopause in women in the United States is 51 years ( range , 41 to 59 years ) , but ovarian production of estrogen and progestin begins to decrease years before the cessation of menses .", "label": "", "metadata": {}, "score": "87.22916"}
{"text": "Although there were too few studies of progestin - only pills to perform meta - analysis , the studies that were identified showed no increase in risk in users of progestin - only pills compared with nonusers .", "label": "", "metadata": {}, "score": "87.44757"}
{"text": "We excluded studies that reported on fewer than three age categories and studies that provided odds ratios for subpopulations only .Time since last use was significantly associated with ovarian cancer incidence , based on a meta - analysis of eight studies .", "label": "", "metadata": {}, "score": "87.60578"}
{"text": "The methodological quality of the studies did not greatly influence the overall hazard ratio estimates .Table 1 .Summary of the systematic review and meta - analysis by Tan et al .", "label": "", "metadata": {}, "score": "87.70904"}
{"text": "RMM and VYT carried out independent review of eligible articles .VYT extracted the data , which was checked by RMM and SJL .RMM and VYT carried out analysis and interpretation of data , with input from JCA .", "label": "", "metadata": {}, "score": "87.75788"}
{"text": "Blank category boxes indicate that this data category was absent from the publication .( DOCX 42 KB ) .12916_2012_740_MOESM3_ESM.pdf Additional file 3 : Funnel plot analysis for lymph node metastasis after excluding studies [ 8 , 64 ] .", "label": "", "metadata": {}, "score": "87.764465"}
{"text": "Hashimoto Y , Skacel M , Adams JC : Roles of fascin in human carcinoma motility and signaling : prospects for a novel biomarker ?Int J Biochem Cell Biol 2005 , 37 : 1787 - 1804 .", "label": "", "metadata": {}, "score": "87.785934"}
{"text": "PubMed .Tsai WC , Jin JS , Chang WK , Chan DC , Yeh MK , Cherng SC , Lin LF , Sheu LF , Chao YC : Association of cortactin and fascin-1 expression in gastric adenocarcinoma : Correlation with clinicopathological parameters .", "label": "", "metadata": {}, "score": "87.91778"}
{"text": "Am J Clin Pathol 2004 , 122 : 642 - 642 .Kefeli M , Sengul AT , Yildiz L , Baris S , Basoglu A , Kandemir B : EMMPRIN and fascin expression in non - small cell lung carcinoma .", "label": "", "metadata": {}, "score": "88.036575"}
{"text": "PMID : 21099604 .Methods Guide for Effectiveness and Comparative Effectiveness Reviews .AHRQ Publication No . 10(12)-EHC063-EF .Rockville , MD : Agency for Healthcare Research and Quality .", "label": "", "metadata": {}, "score": "88.10108"}
{"text": "PubMed View Article .Xue LY , Song YM , Tong T , Luo W , Dong LJ , Zou SM , Zheng S , Bi R , Zhan QM , Lu N : Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma .", "label": "", "metadata": {}, "score": "88.11341"}
{"text": "PubMed .Grothey A , Hashizume R , Sahin AA , McCrea PD : Fascin , an actin - bundling protein associated with cell motility , is upregulated in hormone receptor negative breast cancer .", "label": "", "metadata": {}, "score": "88.15387"}
{"text": "Risk Ratio . tau - squared .Declarations .Acknowledgements .We thank all the authors who provided additional information about their studies .VYT is the recipient of a four - year PhD studentship from the Wellcome Trust ( WT083431 ) .", "label": "", "metadata": {}, "score": "88.372284"}
{"text": "PubMed View Article .Gao X , Wu DH : Fascin expression in human epithelial tumors and its clinical significance .Nan Fang Yi Ke Da Xue Xue 2008 , 28 : 953 - 955 .", "label": "", "metadata": {}, "score": "88.38525"}
{"text": "Research Gaps .There were consistent evidence gaps across all of the literature we reviewed , and the modeling results suggested a few areas that should be prioritized .", "label": "", "metadata": {}, "score": "88.38977"}
{"text": "RESEARCH DESIGN AND METHODS .In 1989 , a local campaign against cancer and heart disease named CLUE II was conducted in Washington County , Maryland .", "label": "", "metadata": {}, "score": "88.39494"}
{"text": "PubMed View Article .Hashimoto Y , Parsons M , Adams JC : Dual actin - bundling and protein kinase C- binding activities of fascin regulate carcinoma cell migration downstream of Rac and contribute to metastasis .", "label": "", "metadata": {}, "score": "88.44057"}
{"text": "Grady D , Gebretsadik T , Kerlikowske K , Ernster V , Petitti D. Hormone replacement therapy and endometrial cancer risk : a meta - analysis .", "label": "", "metadata": {}, "score": "88.74652"}
{"text": "Counties were divided into 3 categories to calculate separate incidence and mortality rates .Cancer Incidence and Mortality Rates The TCR is a population - based cancer surveillance ( reporting ) system that includes incident reports of certain benign , borderline , in situ , and malignant neoplasms occurring in Texas residents .", "label": "", "metadata": {}, "score": "88.825485"}
{"text": "EB CME is clinical content presented with practice recommendations supported by evidence that has been systematically reviewed by an AAFP - approved source .This statement summarizes the U.S. Preventive Services Task Force ( USPSTF ) recommendations on hormone therapy for the prevention of chronic conditions in post - menopausal women and the supporting scientific evidence and updates the Task Force 's 2002 recommendations on hormone replacement therapy .", "label": "", "metadata": {}, "score": "88.87349"}
{"text": "To address if the variations in methodological quality of the studies were possible sources of heterogeneity , we carried out subgroup analysis by methodological quality scores .", "label": "", "metadata": {}, "score": "88.917984"}
{"text": "The forms for the researchers , created via the DistillerSR data synthesis software , contained further data abstraction instructions .Risk - of - Bias Assessment of Individual Studies .", "label": "", "metadata": {}, "score": "89.10187"}
{"text": "In these situations , a grade of \" insufficient \" was assigned .Applicability .To assess applicability , we used the PICOTS format to identify specific issues that could limit the applicability of individual studies or a body of evidence , as recommended in the \" Methods Guide .", "label": "", "metadata": {}, "score": "89.14484"}
{"text": "PubMed View Article .Qin YR , Tang H , Qiao JJ , Li FF , Ai JY : Expression of fascin in human esophageal squamous cell carcinoma and its clinical significance .", "label": "", "metadata": {}, "score": "89.19794"}
{"text": "4 37 As a result , an absolute risk reduction of one in 1000 is probably a reasonable threshold where the potential benefit likely outweighs the potential risks for most patients .", "label": "", "metadata": {}, "score": "89.24729"}
{"text": "Pharmacodynamics .There are no pharmacodynamic data for MINIVELLE .Pharmacokinetics .Absorption .Estradiol pharmacokinetics were characterized in a separate open - label , single - center , randomized , singledose , three - way crossover study conducted in 36 healthy , non - smoking postmenopausal women ( aged 40 to 65 years ) .", "label": "", "metadata": {}, "score": "89.248566"}
{"text": "Hashimoto Y , Skacel M , Adams J : Roles of fascin in human carcinoma motility and signaling : prospects for a novel biomarker ?Int J Biochem Cell Biol 2005 , 37 : 1787 - 804 .", "label": "", "metadata": {}, "score": "89.346436"}
{"text": "[51 ] was excluded from the meta - analysis as it had presented adjusted HRs and could not be pooled with the RRs estimated in the above studies .", "label": "", "metadata": {}, "score": "89.736244"}
{"text": "Higgins JP , Thompson SG , Deeks JJ , Altman DG : Measuring inconsistency in meta - analyses .BMJ 2003 , 327 : 557 - 560 .", "label": "", "metadata": {}, "score": "89.77907"}
{"text": "With input from AHRQ , the CDC , and a Technical Expert Panel of external stakeholders , we defined Key Questions using the general approach of specifying the population of interest , interventions , comparators , outcomes , timing of outcomes , and settings ( PICOTS ) .", "label": "", "metadata": {}, "score": "89.85965"}
{"text": "We did not contact any organizations to obtain unpublished results and we did not identify any on - going studies from our systematic review .Authors of conference abstracts were contacted for the published report .", "label": "", "metadata": {}, "score": "89.8718"}
{"text": "After applying inclusion and exclusion criteria at the title - and - abstract level , 1,919 full - text articles were retrieved and screened .Of those , 1,671 were excluded at the full - text screening stage , leaving 248 articles ( representing 157 unique studies ) for data abstraction .", "label": "", "metadata": {}, "score": "89.92522"}
{"text": "PubMed View Article .Chen L , Yang S , Jakoncic J , Zhang JJ , Huang XY : Migrastatin analogues target fascin to block tumour metastasis .", "label": "", "metadata": {}, "score": "89.961716"}
{"text": "NCI Cancer Surveillance Monograph Series , Number 4 .Bethesda , Maryland : National Cancer Institute ; 2003 .NIH Publication No . 03 - 5417 .", "label": "", "metadata": {}, "score": "89.969955"}
{"text": "Erdogan G , Pestereli HE , Colak T , Karaveli FS , Akaydin M : Fascin expression in invasive ductal carcinoma of breast .Turk Patoloji Dergisi / Turk J Pathol 2010 , 26 : 130 - 135 .", "label": "", "metadata": {}, "score": "89.99094"}
{"text": "Ann Intern Med 2002 ; 137 : 305 -12 .Moss SM , Cuckle H , Evans A , Johns L , Waller M , Bobrow L , et al .", "label": "", "metadata": {}, "score": "90.03036"}
{"text": "Systematic evidence review no . 13 .Agency for Healthcare Research and Quality , 2002 .Espeland MA , Rapp SR , Shumaker SA , Brunner R , Manson JE , Sherwin BB , et al .", "label": "", "metadata": {}, "score": "90.087746"}
{"text": "Authors ' information .VK is a Clinical Biochemist at the University Health Network in Toronto and an Assistant Professor at the Faculty of Medicine , University of Toronto .", "label": "", "metadata": {}, "score": "90.14275"}
{"text": "The mean estradiol pharmacokinetics parameters are summarized in Table 2 . AUC and Cmax are dose proportional from 0.025 mg to 0.1 mg per day .", "label": "", "metadata": {}, "score": "90.24102"}
{"text": "After data extraction , we determined the feasibility of completing a quantitative synthesis by assessing the volume of relevant literature , the conceptual homogeneity of studies , and the completeness of results reporting .", "label": "", "metadata": {}, "score": "90.25316"}
{"text": "Table A. Summary of inclusion and exclusion criteria .Study Characteristic .Inclusion Criteria .Exclusion Criteria .a If the purpose of OC use was unclear , it was assumed to be for contraception .", "label": "", "metadata": {}, "score": "90.50548"}
{"text": "Altman DG : Systematic reviews of evaluations of prognostic variables .BMJ 2001 , 323 : 224 - 228 .PubMed View Article .Pre - publication history .", "label": "", "metadata": {}, "score": "90.629555"}
{"text": "A significant correlation with aggressive clinical behavior .Lab Invest 2003 , 83 : 30A. J Gastroenterol Hepatol 2011 , 26 : 225 .Zheng HC , Zheng YS , Xia P , Xu XY , Xing YN , Takahashi H , Guan YF , Takano Y : The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes .", "label": "", "metadata": {}, "score": "90.68721"}
{"text": "Laura Rees Willett , MD Robert Wood Johnson Medical School New Brunswick , New Jersey , USA .References .Ridker PM , Cook NR , Lee IM , et al .", "label": "", "metadata": {}, "score": "90.70601"}
{"text": "Grading the strength of a body of evidence when comparing medical interventions .In : Agency for Healthcare Research and Quality .Methods Guide for Comparative Effectiveness Reviews [ posted July 2009].", "label": "", "metadata": {}, "score": "90.73237"}
{"text": "In addition , we may expect that the effects of SES will be smaller in magnitude by using ecologic associations rather than individual associations by SES .", "label": "", "metadata": {}, "score": "90.7854"}
{"text": "PubMed View Article .Darnel AD , Behmoaram E , Vollmer RT , Corcos J , Bijian K , Sircar K , Su J , Jiao JS , Alaoui - Jamali MA , Bismar TA : Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer .", "label": "", "metadata": {}, "score": "90.96013"}
{"text": "Data extraction .Data were extracted onto standardized pro forma by one assessor ( VYT ) and then double - checked by two others ( RMM and SJL ) .", "label": "", "metadata": {}, "score": "91.01755"}
{"text": "These effects are considered to underlie the observed correlation between fascin-1 expression and clinical aggressiveness in human carcinomas [ 2 - 4 ] .Fascin-1 was recently implicated as the binding partner of the metastasis inhibitory small molecule , macroketone , and this has further increased interest in its potential as a therapeutic target [ 13 , 14 ] .", "label": "", "metadata": {}, "score": "91.0966"}
{"text": "Effects on Vasomotor Symptoms .There have been no efficacy and safety trials conducted with MINIVELLE .In a pharmacokinetic study , MINIVELLE was shown to be bioequivalent to Vivelle .", "label": "", "metadata": {}, "score": "91.18303"}
{"text": "We excluded two mammography trials on the basis of the Cochrane quality ratings of \" biased \" ( Edinburgh ) 15 or \" likely biased \" ( Two County : Kopparberg ) .", "label": "", "metadata": {}, "score": "91.20007"}
{"text": "In each funnel plot analysis , black dots represent each study 's effect estimate ( drawn on a log scale ) plotted against its standard error .", "label": "", "metadata": {}, "score": "91.31999"}
{"text": "Send correspondence to David R. Risser , PhD , MPH , Cancer Epidemiology and Surveillance Branch MC 1928 , Texas Department of State Health Services , PO Box 149347 , Austin , TX 78714 - 9347 ; e - mail : David.Risser@dshs.state.tx.us .", "label": "", "metadata": {}, "score": "91.48838"}
{"text": "Egger M , Davey Smith G , Schneider M , Minder C : Bias in meta - analysis detected by a simple , graphical test .", "label": "", "metadata": {}, "score": "91.55495"}
{"text": "We used the combined Swedish study , 22 which aggregated four Swedish trials , 16 23 24 25 and presented the data stratified by age to focus on older participants aged 55 - 74 years .", "label": "", "metadata": {}, "score": "91.76828"}
{"text": "See \" Clinical Quiz \" on page 221 .", "label": "", "metadata": {}, "score": "91.86796"}
{"text": "PubMed View Article .Al - Alwan M , Olabi S , Ghebeh H , Barhoush E , Tulbah A , Al - Tweigeri T , Ajarim D , Adra C : Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis - associated molecules .", "label": "", "metadata": {}, "score": "92.38522"}
{"text": "Electronic supplementary material .12916_2012_740_MOESM1_ESM.docx Additional file 1 : Supplementary data on the data extraction and analysis methods .Search terms used .Newcastle - Ottawa Scale results for studies analysing mortality .", "label": "", "metadata": {}, "score": "92.56331"}
{"text": "Results .The main results of the review are presented in this Executive Summary organized by KQ ; more detailed descriptions are provided in the full report .", "label": "", "metadata": {}, "score": "92.60242"}
{"text": "Imprecise .Imprecise .Moderate Decreased cause - specific mortality .Survival among women with ovarian cancer .Ever vs. never use . 1 ( 676 women ) .", "label": "", "metadata": {}, "score": "92.64067"}
{"text": "PubMed View Article .Kim SJ , Choi IJ , Cheong TC , Lee SJ , Lotan R , Park SH , Chun KH : Galectin-3 increases gastric cancer cell motility by up - regulating fascin-1 expression .", "label": "", "metadata": {}, "score": "92.67691"}
{"text": "Effect .Comparison .Number of Studies ( Women and/or Person - Years ) .SOE and Magnitude of Effect ( 95 % CI ) .", "label": "", "metadata": {}, "score": "92.79964"}
{"text": "PubMed View Article .Zhao Q , Shen JH , Shen ZY , Wu ZY , Xu XE , Xie JJ , Wu JY , Huang Q , Lu XF , Li EM , Xu LY : Phosphorylation of fascin decreases the risk of poor survival in patients with esophageal squamous cell carcinoma .", "label": "", "metadata": {}, "score": "92.851654"}
{"text": "Heterogeneity was assessed by performing Cochran 's Q test .The I 2 statistic was calculated as a quantitative measure of the degree of inconsistency across studies , where 0 % indicates no heterogeneity and larger percentages indicate increasing heterogeneity [ 28 ] .", "label": "", "metadata": {}, "score": "92.98934"}
{"text": "Hashimoto Y , Kim DJ , Adams JC : The roles of fascins in health and disease .J Pathol 2011 , 224 : 289 - 300 .", "label": "", "metadata": {}, "score": "93.150665"}
{"text": "Table F shows the strength of evidence for the effect of OC use on cervical cancer .Differences between studies precluded meta - analysis .Because persistent HPV infection is a cause of cervical cancer , and because OC users may have other factors that put them at a higher risk of acquiring HPV , restricting analysis of the association between OCs and cervical cancer to HPV - positive women may be most informative .", "label": "", "metadata": {}, "score": "93.21251"}
{"text": "Use in Specific Populations .No pharmacokinetic studies were conducted with MINIVELLE in specific populations , including patients with renal or hepatic impairment .Adhesion and Adhesive Residue .", "label": "", "metadata": {}, "score": "93.49284"}
{"text": "There were no subjects who had medium adhesive residue .Of the 208 MINIVELLE observations , 54 percent had light adhesive residue and 46 percent had no adhesive residue .", "label": "", "metadata": {}, "score": "93.60334"}
{"text": "Methods .This systematic review was conducted in accordance with PRISMA guidelines , using fixed and random effects models , as appropriate , to undertake meta - analysis .", "label": "", "metadata": {}, "score": "93.62355"}
{"text": "290 - 2007 - 10066-I. ) AHRQ Publication No . 13-E002-EF .Rockville , MD : Agency for Healthcare Research and Quality .", "label": "", "metadata": {}, "score": "93.73604"}
{"text": "Method used to derive hazard ratios from the Kaplan - Meier curve analysis .( DOCX 33 KB ) .12916_2012_740_MOESM2_ESM.docx Additional file 2 : Study characteristics and key results of papers included in our meta - analysis .", "label": "", "metadata": {}, "score": "93.880424"}
{"text": "PubMed View Article .Hashimoto Y , Shimada Y , Kawamura J , Yamasaki S , Imamura M : The prognostic relevance of fascin expression in human gastric carcinoma .", "label": "", "metadata": {}, "score": "94.079834"}
{"text": "Both have an interest in novel biomarker discovery and validation using proteomics and mass spectrometry .Abbreviations .IHC : . immunohistochemistry .Declarations .Competing interests .", "label": "", "metadata": {}, "score": "94.08899"}
{"text": "The potential for search and inclusion bias in our meta - analysis is considerably reduced as we conducted a comprehensive search of four databases for papers published in all languages .", "label": "", "metadata": {}, "score": "94.1369"}
{"text": "Excretion .Estradiol , estrone and estriol are excreted in the urine along with glucuronide and sulfate conjugates .The mean half - life values of estradiol calculated from treatment groups in the bioequivalence study and doseproportionality study after dosing with the MINIVELLE ranged from 6.2 to 7.9 hours .", "label": "", "metadata": {}, "score": "94.166885"}
{"text": "Articles meeting eligibility criteria were included for data abstraction .All screening decisions were made and tracked in a DistillerSR database ( Evidence Partners , Manotick , ON , Canada ) .", "label": "", "metadata": {}, "score": "94.24577"}
{"text": "PubMed .Tierney JF , Stewart LA , Ghersi D , Burdett S , Sydes MR : Practical methods for incorporating summary time - to - event data into meta - analysis .", "label": "", "metadata": {}, "score": "94.406555"}
{"text": "One researcher abstracted the data , and the second reviewed the completed abstraction form alongside the original article to check for accuracy and completeness .Disagreements were resolved by consensus or by obtaining a third researcher 's opinion if consensus could not be reached by the first two researchers .", "label": "", "metadata": {}, "score": "94.52498"}
{"text": "Gut 2002 ; 50 : 840 -4 .Mandel JS , Bond JH , Church TR , Snover DC , Bradley GM , Schuman LM , et al .", "label": "", "metadata": {}, "score": "94.63478"}
{"text": "Submissions received through this mechanism were reviewed , and relevant citations were screened against the review inclusion / exclusion criteria .Inclusion and Exclusion Criteria .", "label": "", "metadata": {}, "score": "94.77341"}
{"text": "Consistent .Direct .Imprecise .Mortality .Ever vs. never use . 2 ( 46,112 women in 1 study and 602,700 person - years in 1 study ) .", "label": "", "metadata": {}, "score": "94.82959"}
{"text": "PubMed View Article .Hashimoto Y , Kim DJ , Adams JC : The role of fascins in health and disease .J Pathol 2011 , 224 : 289 - 300 .", "label": "", "metadata": {}, "score": "94.96599"}
{"text": "For papers or conference abstracts where data were missing or not clear , authors were contacted requesting further information that would enable us to include their data in our meta - analysis .", "label": "", "metadata": {}, "score": "95.03974"}
{"text": "Hendrix SL , et al .Effects of Conjugated Equine Estrogen on Stroke in the Women 's Health Initiative .Circulation .Last reviewed on RxList : 11/30/2012 This monograph has been modified to include the generic and brand name in many instances .", "label": "", "metadata": {}, "score": "95.22339"}
{"text": "Funding :This work was supported by the Veterans Affairs Medical Center , San Francisco , CA .The funders had no role in the design and conduct of the study ; collection , management , analysis , and interpretation of the data ; preparation , review , or approval of the manuscript ; and the decision to submit the manuscript for publication .", "label": "", "metadata": {}, "score": "95.334656"}
{"text": "Consistent .Direct .Precise .Moderate Overall protective effect for ever use , which is greater for longer durations of use .Key Question 5 .", "label": "", "metadata": {}, "score": "95.40493"}
{"text": "Lancet 2010 ; 375 : 1624 -33 .Log in or register : .Download this article to citation manager .Lee Sei J , Boscardin W John , Stijacic - Cenzer Irena , Conell - Price Jessamyn , O'Brien Sarah , Walter Louise C et al .", "label": "", "metadata": {}, "score": "95.6221"}
{"text": "Quality of studies .The methodological quality of the papers was assessed using the Newcastle - Ottawa scaling method [ 27 ] .Meta - analysis results .", "label": "", "metadata": {}, "score": "95.907425"}
{"text": "Results of the CE plus MPA substudy , which included 16,608 women ( average 63 years of age , range 50 to 79 ; 83.9 percent White , 6.8 percent Black , 5.4 percent Hispanic , 3.9 percent Other ) are presented in Table 4 .", "label": "", "metadata": {}, "score": "96.16971"}
{"text": "Distribution .The distribution of exogenous estrogens is similar to that of endogenous estrogens .Estrogens are widely distributed in the body and are generally found in higher concentrations in the sex hormone target organs .", "label": "", "metadata": {}, "score": "96.306564"}
{"text": "We stratified analyses by study type ( i.e. , case - control , cohort , pooled analyses ) .All meta - analyses were performed using Comprehensive Meta - Analysis Version 2.0 .", "label": "", "metadata": {}, "score": "96.31273"}
{"text": "Hormone therapy .Obstet Gynecol .2004;104(4 suppl):S1 - 4 .Mosca L , Appel LJ , Benjamin EJ , Berra K , Chandra - Strobos N , Fabunmi RP , et al .", "label": "", "metadata": {}, "score": "96.704895"}
{"text": "PubMed View Article .Hashimoto Y , Ito T , Inoue H , Okumura T , Tanaka E , Tsunoda S , Higashiyama M , Watanabe G , Imamura M , Shimada Y : Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma .", "label": "", "metadata": {}, "score": "96.94579"}
{"text": "This analysis examined the relationship between county - level SES and cancer incidence and mortality rates in Texas .The purpose of the analysis is to give a basic demonstration of disparities in cancer incidence and mortality rates by SES simply by comparing the characteristics of the county people live in .", "label": "", "metadata": {}, "score": "97.01872"}
{"text": "Dis Markers 2007 , 23 : 153 - 160 .PubMed View Article .Anal Quant Cytol Histol 2010 , 32 : 90 - 101 .", "label": "", "metadata": {}, "score": "97.05333"}
{"text": "( PDF 11 KB ) .Competing interests .The authors declare that they have no conflicts of interest .Authors ' contributions .RMM and JCA had the idea for and designed the study .", "label": "", "metadata": {}, "score": "97.090805"}
{"text": "The authors acknowledge the State of Maryland , the Maryland Cigarette Restitution Fund , and the National Program of Cancer Registries of the Centers for Disease Control and Prevention for the funds that helped support the availability of the cancer registry data .", "label": "", "metadata": {}, "score": "97.105415"}
{"text": "Consistent .Direct .Imprecise .Time since last use . 8 ( 210,069 women and 1,083,000 person - years ) .High .Inconsistent .", "label": "", "metadata": {}, "score": "97.13201"}
{"text": "Center for Health Statistics and collected by the DSHS Vital Statistics Unit .These files contained demographic and cause - of - death information from Texas death certificates for all deaths occurring among Texas residents .", "label": "", "metadata": {}, "score": "97.17676"}
{"text": "Minivelle .\"The U.S. Food and Drug Administration today approved Osphena ( ospemifene ) to treat women experiencing moderate to severe dyspareunia ( pain during sexual intercourse ) , a symptom of vulvar and vaginal atrophy due to menopause .", "label": "", "metadata": {}, "score": "98.26181"}
{"text": "VYT prepared the first draft .All authors were involved in writing the manuscript and approved the final version .Authors ' Affiliations .School of Social and Community Medicine , University of Bristol .", "label": "", "metadata": {}, "score": "98.47646"}
{"text": "Kopparberg and Ostergotland studies make up the Two - County Study .16 We used the synthesized data from the Combined Swedish Trials for our analysis 22 .", "label": "", "metadata": {}, "score": "99.55199"}
{"text": "Examining variation in cancer rates by SES can help identify health disparities and target areas for cancer control activities .The Texas Cancer Registry ( TCR ) collects data on every newly diagnosed case of cancer in Texas , including personal and demographic data , but does not collect data related directly to SES .", "label": "", "metadata": {}, "score": "99.60509"}
{"text": "Abbreviations .MeSH : .Medical Subject Headings .mRNA : . messengerRNA .PRISMA : .Preferred Reporting Items for Systematic Reviews and Meta - Analyses .", "label": "", "metadata": {}, "score": "99.69614"}
{"text": "Authors ' contributions .VK and EPD contributed to the conception and design of this manuscript .VK drafted the manuscript and EPD made substantial contributions in revising it .", "label": "", "metadata": {}, "score": "100.07027"}
{"text": "Selection of studies .The title and abstracts of all retrieved papers were then assessed using the pre - specified inclusion criteria by one author ( VYT ) .", "label": "", "metadata": {}, "score": "100.61398"}
{"text": "H.-C.Y. researched data , contributed to discussion , wrote the manuscript , had full access to all data in the study , and takes responsibility for the integrity of data and the accuracy of the data analysis .", "label": "", "metadata": {}, "score": "100.62422"}
{"text": "Torgerson DJ , Bell - Syer SE .Hormone replacement therapy and prevention of nonvertebral fractures : a meta - analysis of randomized trials .JAMA .", "label": "", "metadata": {}, "score": "100.94855"}
{"text": "Nicotine Tob Res .Hanson MD , Chen E. Socioeconomic status and health behaviors in adolescence : a review of the literature .J Behav Med .", "label": "", "metadata": {}, "score": "101.78279"}
{"text": "Precise .Moderate 0.58 ( 0.45 to 0.73 ) .Duration of use . 8 ( 352,915 women across 5 studies and 3,981,072 person - years across 3 studies ) .", "label": "", "metadata": {}, "score": "102.19463"}
{"text": "These vary in proportion from tissue to tissue .Circulating estrogens modulate the pituitary secretion of the gonadotropins , luteinizing hormone ( LH ) and follicle stimulating hormone ( FSH ) through a negative feedback mechanism .", "label": "", "metadata": {}, "score": "102.21863"}
{"text": "Duration of use . 15 ( 547,363 women and 3,493,072 person - years ) .Medium .Consistent .Direct .Precise .Age at first use . 6 ( 111,817 women ) .", "label": "", "metadata": {}, "score": "102.28619"}
{"text": "Non - English articles g .Study Selection .Using the inclusion and exclusion criteria described in Table A , two investigators independently reviewed the titles and abstracts of articles retrieved through the search strategies for potential relevance to the KQs .", "label": "", "metadata": {}, "score": "102.369064"}
{"text": "Lancet 2006 ; 368 : 2053 -60 .Tabar L , Vitak B , Chen HH , Duffy SW , Yen MF , Chiang CF , et al .", "label": "", "metadata": {}, "score": "102.42326"}
{"text": "Ever vs. never use . 7 ( 308,198 women across 4 studies and 3,981,072 person - years across 3 studies ) .Medium .Consistent .", "label": "", "metadata": {}, "score": "102.48488"}
{"text": "Organization of Report and Executive Summary .This report departs from the standard AHRQ evidence - report organization .The evidence is instead presented in four topic - focused sections .", "label": "", "metadata": {}, "score": "103.181335"}
{"text": "Abstract .Background .Fascin-1 is an actin - bundling protein expressed in many human carcinomas , although absent from most normal epithelia .Fascin-1 promotes filopodia formation , migration and invasion in carcinoma cells ; in mouse xenograft tumor models it contributes to metastasis .", "label": "", "metadata": {}, "score": "103.25557"}
{"text": "We supplemented the electronic searches with a manual search of citations from a set of key review articles .The reference lists from these articles were hand - searched and cross - referenced against our library of database search results .", "label": "", "metadata": {}, "score": "103.45149"}
{"text": "Global Index g . a Adapted from numerous WHI publications .b Results are based on centrally adjudicated data .c Nominal confidence intervals unadjusted for multiple looks and multiple comparisons .", "label": "", "metadata": {}, "score": "103.94259"}
{"text": "Strength of the Body of Evidence .The strength of evidence for each Key Question and outcome was assessed using the approach described in the \" Methods Guide . \" 3,5 The evidence was evaluated using the four required domains of ( 1 ) risk of bias , ( 2 ) consistency , ( 3 ) directness , and ( 4 ) precision .", "label": "", "metadata": {}, "score": "104.582016"}
{"text": "20 21 All four trials were large ; the number of participants ranged from 30 964 to 150 251 , enrolling patients aged 45 - 80 years .", "label": "", "metadata": {}, "score": "105.60556"}
{"text": "We performed analyses using SAS version 9.2 ( Cary , NC ) and Stata / SE version 10.0 ( College Station , TX ) .RESULTS .", "label": "", "metadata": {}, "score": "105.676834"}
{"text": "The primary source of estrogen in normally cycling adult women is the ovarian follicle , which secretes 70 to 500 mcg of estradiol daily , depending on the phase of the menstrual cycle .", "label": "", "metadata": {}, "score": "107.210686"}
{"text": "SO'B extracted data from publications and made critical revisions to the manuscript .LCW provided oversight over all aspects of this project .SJL is the study guarantor .", "label": "", "metadata": {}, "score": "107.68133"}
{"text": "20 The overall evidence supports harmful effects of hormone therapy on cognitive function , although the clinical relevance of this difference in cognitive function is unclear .", "label": "", "metadata": {}, "score": "108.38615"}
{"text": "Medium .Insufficient Mixed results for risk of death with ever use , and no trend toward increased protective effect with longer duration of use .", "label": "", "metadata": {}, "score": "108.44646"}
{"text": "Notes .Cite this as : BMJ 2012;345:e8441 .Footnotes .We thank Laszlo Tabar , who provided data from the Two - County : Ostergotland Mammography study ; and Sue Moss and J H Scholefield , who provided data from the Nottingham Faecal Occult Blood Test study .", "label": "", "metadata": {}, "score": "108.596855"}
{"text": "Electronic supplementary material .The online version of this article ( doi : 10 .1186/\u200b1741 - 7015 - 11 - 52 ) contains supplementary material , which is available to authorized users .", "label": "", "metadata": {}, "score": "109.62329"}
{"text": "Thus , estrone and the sulfate conjugated form , estrone sulfate , are the most abundant circulating estrogens in postmenopausal women .Estrogens act through binding to nuclear receptors in estrogen - responsive tissues .", "label": "", "metadata": {}, "score": "110.80605"}
{"text": "Irene L. Wapnir , James J. Dignam , Bernard Fisher , Eleftherios P. Mamounas , Stewart J. Anderson , Thomas B. Julian , Stephanie R. Land , Richard G. Margolese , Sandra M. Swain , Joseph P. Costantino , Norman Wolmark .", "label": "", "metadata": {}, "score": "111.64697"}
{"text": "Metabolism .Exogenous estrogens are metabolized in the same manner as endogenous estrogens .Circulating estrogens exist in a dynamic equilibrium of metabolic interconversions .These transformations take place mainly in the liver .", "label": "", "metadata": {}, "score": "111.756355"}
{"text": "Searches of PubMed , Embase , and the Cochrane Database of Systematic Reviews yielded 7,196 citations , 767 of which were duplicates .Manual searching and contacts with drug manufacturers via the scientific information packet requests identified 47 additional citations , for a total of 6,476 .", "label": "", "metadata": {}, "score": "112.09662"}
{"text": "22Although using the age stratified curves from the combined Swedish study prevented us from accounting for heterogeneity between individual Swedish trials , we were able to exclude most younger women ( age 40 - 54 years ) and focus on older women ( 55 - 74 years ) for our analysis .", "label": "", "metadata": {}, "score": "112.64241"}
{"text": "Estrogens also undergo enterohepatic recirculation via sulfate and glucuronide conjugation in the liver , biliary secretion of conjugates into the intestine , and hydrolysis in the intestine followed by reabsorption .", "label": "", "metadata": {}, "score": "114.34532"}
{"text": "All citations were imported into an electronic database ( EndNote \u00ae Version X4 ; Thomson Reuters , Philadelphia , PA ) .We did not systematically search gray literature databases beyond ClinicalTrials.gov , since the high volume of literature identified through our searches of peer - reviewed articles made it unlikely that further searching of gray literature would substantially increase the chances of identifying relevant data that would meet inclusion criteria .", "label": "", "metadata": {}, "score": "114.608894"}
{"text": "The Figure presents a county map of Texas showing how each county was categorized by SES .Most of the Low SES counties are found close to the Texas - Mexico border .", "label": "", "metadata": {}, "score": "120.79141"}
{"text": "[ PubMed ID : 14519797 ] .Copyright \u00a9 American College of Physicians .The information contained herein should never be used as a substitute for good clinical judgment .", "label": "", "metadata": {}, "score": "123.9374"}
{"text": "\u00a9 Tan et al ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd.Table of Contents .Background .", "label": "", "metadata": {}, "score": "127.27033"}
{"text": "PubMed View Article .Pre - publication history .Copyright .\u00a9 Kulasingam and Diamandis ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "139.9476"}
